Antibacterial agents
Patent Information
- Application Number
- JP2024512554
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2022-03-30
- Filing Date
- 2023-03-28
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2043-03-28
AI Technical Summary
【0018】 本発明の抗菌剤は、ブロックイソシアネートを含む。ブロックイソシアネートが、ポリイソシアネートの封止残基(A)と、抗菌性-非ブロック封止基(B)と、非抗菌性-ブロック封止基(C)とを備える。そして、抗菌性-非ブロック封止基(B)が、4級アンモニウム基を含む。そのため、上記の抗菌剤は、優れた抗菌性を有し、かつ、比較的高い自由度で樹脂中に固定可能である。
Smart Images

Figure 0007581569000001 
Figure 0007581569000002 
Figure 0007581569000003
Abstract
Description
[Technical field]
[0001] The present invention relates to antibacterial agents. [Background technology]
[0002] Conventionally, compounds containing quaternary ammonium salts have been known as antibacterial agents, and methods of using such antibacterial agents by fixing them to the surfaces of various articles have also been known.
[0003] More specifically, a method has been proposed in which an article containing a resin component having a carboxyl group is contacted with a solution of an antibacterial agent containing an ethoxysilane-based quaternary ammonium salt, thereby applying the ethoxysilane-based quaternary ammonium salt to the surface of the article (see, for example, Patent Document 1).
[0004] In this method, the antibacterial agent is fixed to the article by a reaction between the carboxyl group of a resin component having a carboxyl group and the ethoxysilane group of an ethoxysilane-based quaternary ammonium salt. [Prior art documents] [Patent documents]
[0005] [Patent Document 1] International Publication No. 2013 / 047642 Summary of the Invention [Problem to be solved by the invention]
[0006] However, in the method described in Patent Document 1, it is necessary to select a resin component having a carboxyl group as the article (substance to be immobilized) and an ethoxysilane-based quaternary ammonium salt as the antibacterial agent (substance to be immobilized), which is disadvantageous in that the freedom of selection of the article (substance to be immobilized) is relatively low.
[0007] The present invention provides an antibacterial agent which has excellent antibacterial properties and allows for a relatively high degree of freedom in selecting the substance to be immobilized. [Means for solving the problem]
[0008] The present invention [1] is an antibacterial agent comprising a blocked isocyanate, the blocked isocyanate comprising a blocking residue of a polyisocyanate (A), an antibacterial non-blocked blocking group (B), and a non-antibacterial blocked blocking group (C), the blocking residue of the polyisocyanate (A) being obtained by blocking isocyanate groups of a polyisocyanate having a plurality of isocyanate groups, the antibacterial non-blocked blocking group (B) being obtained by blocking at least a portion of the plurality of isocyanate groups in a non-reproducible manner, the non-antibacterial blocked blocking group (C) being obtained by blocking at least a portion of the plurality of isocyanate groups in a reproducible manner, and the antibacterial non-blocked blocking group (B) comprising a quaternary ammonium group.
[0009] The present invention [2] comprises the antibacterial agent according to the above [1], wherein the blocked isocyanate further comprises an antibacterial-blocked capping group (D), in which at least a portion of the multiple isocyanate groups are reproducibly blocked, and the antibacterial-blocked capping group (D) comprises a tertiary ammonium salt.
[0010] The present invention [3] comprises the antibacterial agent according to the above [1] or [2], wherein the blocked isocyanate further comprises a hydrophilic group (E), in which at least a portion of the multiple isocyanate groups are blocked so as to be irreproducible, and the hydrophilic group (E) comprises a polyoxyethylene group.
[0011] The present invention [4] comprises the antibacterial agent according to any one of the above [1] to [3], wherein the blocked isocyanate has not been subjected to a quaternary treatment.
[0012] The present invention [5] relates to the antibacterial agent according to any one of the above [1] to [4], wherein the blocked isocyanate is a reaction product of raw material components, the raw material components having a plurality of isocyanate groups, and comprising: a polyisocyanate (a) for forming the blocking residue (A); an antibacterial-unblocked blocking agent (b) for reacting with at least a portion of the plurality of isocyanate groups to form the antibacterial-unblocked blocking group (B); and a non-antibacterial-blocked blocking agent (c) for reacting with at least a portion of the plurality of isocyanate groups to form the non-antibacterial-blocked blocking group (C), and the antibacterial-unblocked blocking agent (b) comprises a quaternary ammonium group-containing compound.
[0013] The present invention [6] comprises the antibacterial agent according to the above [5], in which the proportion of the antibacterial non-blocking sealing agent (b) is 5 moles or more per 100 moles of isocyanate groups of the polyisocyanate (a).
[0014] The present invention [7] includes the antibacterial agent according to the above [5] or [6], wherein the quaternary ammonium group-containing compound includes a trialkylalkanol ammonium compound.
[0015] The present invention [8] comprises the antibacterial agent according to any one of the above [5] to [7], wherein the raw material components further comprise a tertiary amino group-containing compound (d1) which reacts with at least a portion of the multiple isocyanate groups to add a tertiary amino group, and an acid (d2) which neutralizes at least a portion of the tertiary amino groups to form a tertiary ammonium salt.
[0016] The present invention [9] comprises the antibacterial agent according to any one of the above [5] to [8], wherein the raw material components further comprise a hydrophilic compound (e), and the hydrophilic compound (e) comprises a polyoxyethylene compound.
[0017] The present invention
[10] comprises the antibacterial agent according to any one of the above [1] to [9], wherein the polyisocyanate comprises an araliphatic polyisocyanate derivative. Effect of the Invention
[0018] The antibacterial agent of the present invention contains a blocked isocyanate. The blocked isocyanate comprises a blocking residue of a polyisocyanate (A), an antibacterial non-blocked blocking group (B), and a non-antibacterial blocked blocking group (C). The antibacterial non-blocked blocking group (B) contains a quaternary ammonium group. Therefore, the antibacterial agent has excellent antibacterial properties and can be fixed in a resin with a relatively high degree of freedom. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0019] 1. Antibacterial agents (1) Blocked isocyanate The antibacterial agent contains a blocked isocyanate. The blocked isocyanate is a compound having a latent isocyanate group. The latent isocyanate group is a functional group that can regenerate an isocyanate group (active isocyanate group) by deblocking.
[0020] More specifically, the blocked isocyanate comprises a blocking residue of a polyisocyanate (A), an antibacterial non-blocking blocking group (B), and a non-antibacterial blocked blocking group (C).
[0021] (2) Capped residue of polyisocyanate (A) The blocked residue (A) of the polyisocyanate is the main molecular skeleton of the blocked isocyanate. The blocked residue (A) of the polyisocyanate is the remainder obtained by blocking the isocyanate groups of the polyisocyanate (described later). The blocking includes blocked blocking and non-block blocking.
[0022] (3) Antibacterial - Non-blocking capping group (B) The antibacterial unblocked capping group (B) is formed by irreproducibly blocking at least a portion of the isocyanate groups of a polyisocyanate (described below), i.e., the antibacterial unblocked capping group (B) is an end capping group that cannot be deblocked.
[0023] In addition, the antibacterial non-blocking capping group (B) has antibacterial properties. More specifically, the antibacterial non-blocking capping group (B) contains a quaternary ammonium group.
[0024] The quaternary ammonium group is a cationic group in which four atoms other than hydrogen atoms are bonded to one nitrogen atom. The quaternary ammonium group provides a blocked isocyanate with excellent water dispersibility. The quaternary ammonium group is, for example, neutralized by a counter ion.
[0025] Examples of the quaternary ammonium group include trialkylammonium groups. Examples of the trialkylammonium group include trialkylammonium groups with an alkyl group having 1 to 8 carbon atoms, and preferably trialkylammonium groups with an alkyl group having 1 to 4 carbon atoms. More specifically, examples of the trialkylammonium group include trimethylammonium groups, triethylammonium groups, dimethylethylammonium groups, methyldiethylammonium groups, tripropylammonium groups, and tributylammonium groups. These can be used alone or in combination of two or more kinds. Examples of the trialkylammonium group include trimethylammonium groups.
[0026] Examples of counter ions of the quaternary ammonium group include chloride ions, bromide ions, iodide ions, acetate ions, carbonate ions, phosphate ions, hydroxide ions, citrate ions, tartrate ions, bitartrate ions, and lactate ions. These can be used alone or in combination of two or more. Preferable counter ions include chloride ions, bromide ions, and acetate ions, and more preferably chloride ions.
[0027] The antibacterial-nonblocking capping group (B) is chemically bonded to the capping residue (A) of the polyisocyanate.
[0028] The proportion of the antibacterial non-blocked capping group (B) is, for example, 5 moles or more, preferably 10 moles or more, more preferably 15 moles or more, relative to 100 moles of isocyanate groups of the polyisocyanate (described later) forming the capping residue (A), from the viewpoints of antibacterial properties, water dispersibility and storage stability. The proportion of the antibacterial non-blocked capping group (B) is, for example, 80 moles or less, preferably 60 moles or less, relative to 100 moles of isocyanate groups of the polyisocyanate (described later) forming the capping residue (A), from the viewpoints of durability, and more preferably 40 moles or less, even more preferably 30 moles or less, particularly preferably 25 moles or less, relative to 100 moles of isocyanate groups of the polyisocyanate (described later) forming the capping residue (A), from the viewpoints of water dispersibility and storage stability.
[0029] The proportion of the antibacterial non-blocked capping group (B) is, for example, 5 moles or more, preferably 10 moles or more, more preferably 15 moles or more, from the viewpoints of antibacterial activity, water dispersibility and storage stability, relative to 100 moles in total of the antibacterial non-blocked capping group (B) and the non-antibacterial blocked capping group (C). The proportion of the antibacterial non-blocked capping group (B) is, for example, 80 moles or less, preferably 60 moles or less, from the viewpoints of durability, and more preferably 40 moles or less, even more preferably 30 moles or less, particularly preferably 25 moles or less, relative to 100 moles in total of the antibacterial non-blocked capping group (B) and the non-antibacterial blocked capping group (C), from the viewpoints of water dispersibility and storage stability.
[0030] The proportion of the antibacterial non-blocked capping group (B) is, for example, 2.0 parts by mass or more, preferably 4.5 parts by mass or more, based on 100 parts by mass of the polyisocyanate (described below) forming the capping residue (A). The proportion of the antibacterial non-blocked capping group (B) is, for example, 20.0 parts by mass or less, preferably 15.0 parts by mass or less, based on 100 parts by mass of the polyisocyanate (described below) forming the capping residue (A).
[0031] (4) Non-antibacterial block capping group (C) The non-antibacterial blocked capping group (C) is obtained by blocking at least a portion of the isocyanate groups of a polyisocyanate (described later) in a reproducible manner, i.e., the non-antibacterial blocked capping group (C) is a deblockable latent isocyanate group (blocked isocyanate group).
[0032] The non-antibacterial blocked capping group (C) does not have antibacterial properties. Examples of the non-antibacterial blocked capping group (C) include known latent isocyanate groups (blocked isocyanate groups).
[0033] The non-antibacterial blocked capping group (C) is chemically bonded to the capping residue (A) of the polyisocyanate.
[0034] The proportion of the non-antibacterial blocked capping group (C) is, for example, 20 moles or more, preferably 40 moles or more, from the viewpoint of durability, and more preferably 60 moles or more, even more preferably 70 moles or more, particularly preferably 75 moles or more, from the viewpoint of water dispersibility and storage stability, relative to 100 moles of isocyanate groups of the polyisocyanate (described later) forming the capping residue (A). The proportion of the non-antibacterial blocked capping group (C) is, for example, 95 moles or less, preferably 90 moles or less, more preferably 85 moles or less, from the viewpoint of antibacterial property, water dispersibility and storage stability, relative to 100 moles of isocyanate groups of the polyisocyanate (described later) forming the capping residue (A).
[0035] The proportion of the non-antibacterial block capping group (C) is, for example, 20 moles or more, preferably 40 moles or more, from the viewpoint of durability, and more preferably 60 moles or more, even more preferably 70 moles or more, particularly preferably 75 moles or more, from the viewpoint of water dispersibility and storage stability, relative to a total of 100 moles of the antibacterial non-block capping group (B) and the non-antibacterial block capping group (C). The proportion of the non-antibacterial block capping group (C) is, for example, 95 moles or less, preferably 90 moles or less, more preferably 85 moles or less, from the viewpoint of antibacterial activity, water dispersibility and storage stability, relative to a total of 100 moles of the antibacterial non-block capping group (B) and the non-antibacterial block capping group (C).
[0036] The proportion of the non-antibacterial blocked capping group (C) is, for example, 18.0 parts by mass or more, preferably 22.0 parts by mass or more, based on 100 parts by mass of the polyisocyanate (described below) forming the capping residue (A). The proportion of the non-antibacterial blocked capping group (C) is, for example, 33.0 parts by mass or less, preferably 30.0 parts by mass or less, based on 100 parts by mass of the polyisocyanate (described below) forming the capping residue (A).
[0037] The non-antibacterial blocked capping group (C) is deblocked (dissociated) by heating to regenerate the isocyanate group. The dissociation temperature of the non-antibacterial blocked capping group (C) is, for example, 50° C. or higher. The dissociation temperature of the non-antibacterial blocked capping group (C) is, for example, 150° C. or lower, preferably 140° C. or lower, and more preferably 130° C. or lower.
[0038] (5) Antibacterial Block Cap Group (D) The blocked isocyanate may further comprise an antibacterial-blocked capping group (D). The antibacterial-blocked capping group (D) can improve the reactivity (curability) of the blocked isocyanate.
[0039] The antibacterial blocked capping group (D) is obtained by blocking at least a portion of the isocyanate groups of a polyisocyanate (described below) in a reproducible manner, i.e., the antibacterial blocked capping group (D) is a deblockable latent isocyanate group (blocked isocyanate group).
[0040] The antibacterial-block capping group (D) has antibacterial properties. More specifically, the antibacterial-block capping group (D) may be a tertiary ammonium salt.
[0041] Tertiary ammonium salts are formed, for example, by neutralizing a tertiary amino group with an acid.
[0042] In addition, a tertiary amino group is an amino group in which three atoms other than hydrogen atoms are bonded to one nitrogen atom by single bonds. In other words, an amino group in which atoms other than hydrogen atoms are bonded to one nitrogen atom by double bonds or triple bonds is not a tertiary amino group. In addition, a tertiary amino group may be included in a heterocyclic structure.
[0043] Examples of the tertiary amino group include a dialkylamino group. Examples of the dialkylamino group include a dialkylamino group having an alkyl group with 1 to 8 carbon atoms, and preferably a dialkylamino group having an alkyl group with 1 to 4 carbon atoms. More specific examples of the dialkylamino group include a dimethylamino group, a diethylamino group, a dipropylamino group, a diisopropylamino group, a dibutylamino group, a diisobutylamino group, a di-s-butylamino group, and a di-t-butylamino group. These can be used alone or in combination of two or more kinds. Examples of the dialkylamino group include a dimethylamino group.
[0044] The acid that neutralizes the tertiary amino group may be, for example, an organic acid or an inorganic acid, and preferably, an organic acid. The organic acid may be, for example, a carboxylic acid. The carboxylic acid may be, for example, an acetic acid, a propionic acid, and a lactic acid. These may be used alone or in combination of two or more kinds.
[0045] The antibacterial-blocking capping group (D) is chemically bonded to the capping residue (A) of the polyisocyanate.
[0046] The proportion of the antibacterial blocked capping group (D) is, for example, 0.1 mol or more, preferably 1 mol or more, based on 100 mol of isocyanate groups of the polyisocyanate (described later) forming the capping residue (A) from the viewpoints of antibacterial properties, water dispersibility and storage stability. The proportion of the antibacterial blocked capping group (D) is, for example, 20 mol or less, preferably 10 mol or less, based on 100 mol of isocyanate groups of the polyisocyanate (described later) forming the capping residue (A) from the viewpoints of antibacterial properties, water dispersibility and storage stability.
[0047] The proportion of the antibacterial blocked capping group (D) is, for example, 1 mole or more, preferably 5 moles or more, more preferably 10 moles or more, per 100 moles of the antibacterial non-blocked capping group (B). From the viewpoints of antibacterial activity, water dispersibility, and storage stability, the proportion of the antibacterial blocked capping group (D) is, for example, 40 moles or less, preferably 35 moles or less, more preferably 30 moles or less, per 100 moles of the antibacterial non-blocked capping group (B).
[0048] The proportion of the antibacterial blocked capping group (D) is, for example, 0.1 parts by mass or more, preferably 1.3 parts by mass or more, based on 100 parts by mass of the polyisocyanate (described below) forming the capping residue (A). The proportion of the antibacterial blocked capping group (D) is, for example, 15.0 parts by mass or less, preferably 12.0 parts by mass or less, based on 100 parts by mass of the polyisocyanate (described below) forming the capping residue (A).
[0049] The antibacterial-blocked capping group (D) can be deblocked (dissociated) by heating to regenerate the isocyanate group. However, depending on the temperature conditions, the antibacterial-blocked capping group (D) may not be deblocked (dissociated) and may not regenerate the isocyanate group.
[0050] More specifically, the dissociation temperature of the antibacterial block capping group (D) is preferably higher than the dissociation temperature of the non-antibacterial block capping group (C). If the dissociation temperature of the antibacterial block capping group (D) is higher than the dissociation temperature of the blocking group of the non-antibacterial block capping group (C), the non-antibacterial block capping group (C) can be preferentially dissociated while suppressing the dissociation of the antibacterial block capping group (D). Therefore, when a resin (described below) is formed by the dissociation of the non-antibacterial block capping group (C), the antibacterial block capping group (D) can be fixed to the resin.
[0051] The dissociation temperature of the antibacterial block capping group (D) is, for example, 60° C. or higher, preferably 100° C. or higher. The dissociation temperature of the non-antibacterial block capping group (C) is, for example, 200° C. or lower, preferably 180° C. or lower, more preferably 160° C. or lower.
[0052] The difference between the dissociation temperature of the non-antibacterial block sealing group (C) and the dissociation temperature of the antibacterial block sealing group (D) is, for example, 1° C. or more, preferably 10° C. or more. In addition, the difference between the dissociation temperature of the non-antibacterial block sealing group (C) and the dissociation temperature of the antibacterial block sealing group (D) is, for example, 50° C. or less, preferably 40° C. or less.
[0053] (6) Hydrophilic group (E) The blocked isocyanate may further include a hydrophilic group (E). The hydrophilic group (E) can improve the water dispersibility of the blocked isocyanate.
[0054] The hydrophilic group (E) is formed by blocking at least a part of the isocyanate groups of a polyisocyanate (described later) so that they cannot be regenerated, i.e., the hydrophilic group (E) is a terminal blocking group that cannot be deblocked.
[0055] Examples of the hydrophilic group (E) include anionic groups and nonionic groups, and preferably include nonionic groups. Examples of the nonionic group include polyoxyethylene groups. In the polyoxyethylene group, the repeat number of the oxyethylene unit is, for example, 3 or more, preferably 5 or more. Also, the repeat number of the oxyethylene unit is, for example, 100 or less, preferably 50 or less.
[0056] The hydrophilic group (E) is chemically bonded to the capping residue (A) of the polyisocyanate.
[0057] The ratio of the hydrophilic group (E) is, for example, 0.1 mol or more, preferably 1 mol or more, based on 100 mol of isocyanate groups of the polyisocyanate (described later) forming the capping residue (A) from the viewpoints of antibacterial properties, water dispersibility and storage stability. The ratio of the hydrophilic group (E) is, for example, 20 mol or less, preferably 10 mol or less, based on 100 mol of isocyanate groups of the polyisocyanate (described later) forming the capping residue (A) from the viewpoints of antibacterial properties, water dispersibility and storage stability.
[0058] The proportion of the hydrophilic group (E) is, for example, 1 mol or more, preferably 3 mol or more, and more preferably 5 mol or more, per 100 mol of the antibacterial non-blocking capping group (B). In addition, the ratio of the hydrophilic group (E) is, for example, 30 moles or less, preferably 25 moles or less, and more preferably 20 moles or less, per 100 moles of the antibacterial non-blocking blocking group (B), from the viewpoints of antibacterial activity, water dispersibility, and storage stability.
[0059] The ratio of the hydrophilic group (E) is, for example, 0.1 parts by mass or more, preferably 1.0 parts by mass or more, based on 100 parts by mass of the polyisocyanate (described later) forming the capping residue (A). The ratio of the hydrophilic group (E) is, for example, 65.0 parts by mass or less, preferably 32.0 parts by mass or less, based on 100 parts by mass of the polyisocyanate (described later) forming the capping residue (A).
[0060] 2. Method for producing blocked isocyanate (1) Raw material components The blocked isocyanate can be obtained as a reaction product of the following raw material components: The raw material components of the blocked isocyanate include, for example, polyisocyanate (a), antibacterial non-blocking sealant (b), and non-antibacterial blocked sealant (c).
[0061] (2) Polyisocyanate (a) The polyisocyanate (a) is a raw material compound for forming the capping residue (A). The polyisocyanate (a) has a plurality of isocyanate groups. Examples of the polyisocyanate (a) include polyisocyanate monomers and polyisocyanate derivatives.
[0062] Examples of polyisocyanate monomers include aliphatic polyisocyanates, aromatic polyisocyanates, and araliphatic polyisocyanates.
[0063] Examples of aliphatic polyisocyanates include ethylene diisocyanate, trimethylene diisocyanate, 1,4-tetramethylene diisocyanate, 1,5-pentamethylene diisocyanate, 1,6-hexamethylene diisocyanate, trimethylhexamethylene diisocyanate, and 2,6-diisocyanate methyl caproate. These can be used alone or in combination of two or more.
[0064] In addition, the aliphatic polyisocyanate monomer may also include an alicyclic polyisocyanate monomer. Examples of the alicyclic polyisocyanate monomer include 1,3-cyclopentane diisocyanate, 1,3-cyclopentene diisocyanate, 1,4-cyclohexane diisocyanate, 1,3-cyclohexane diisocyanate, 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, methylene bis(cyclohexyl isocyanate), methyl-2,4-cyclohexane diisocyanate, methyl-2,6-cyclohexane diisocyanate, norbornane diisocyanate, and bis(isocyanatomethyl)cyclohexane. These may be used alone or in combination of two or more.
[0065] Examples of aromatic polyisocyanates include tolylene diisocyanate, phenylene diisocyanate, 4,4'-diphenyl diisocyanate, 1,5-naphthalene diisocyanate, diphenylmethane diisocyanate, 4,4'-toluidine diisocyanate, and 4,4'-diphenyl ether diisocyanate. These can be used alone or in combination of two or more kinds.
[0066] Examples of aromatic aliphatic polyisocyanates include xylylene diisocyanate, tetramethyl xylylene diisocyanate, and ω,ω'-diisocyanate-1,4-diethylbenzene. These can be used alone or in combination of two or more kinds.
[0067] The polyisocyanate derivative is derived from the polyisocyanate monomer described above. Examples of the polyisocyanate derivative include isocyanurate modified products, iminooxadiazinedione modified products, triol adducts, allophanate modified products, biuret modified products, urea modified products, oxadiazinetrione modified products, carbodiimide modified products, uretdione modified products, and uretonimine modified products. These can be used alone or in combination of two or more kinds. The polyisocyanate derivative is preferably an isocyanurate modified product.
[0068] The polyisocyanate (a) can be used alone or in combination of two or more kinds. From the viewpoint of curability (reactivity), the polyisocyanate (a) preferably contains a polyisocyanate derivative, and more preferably consists of a polyisocyanate derivative.
[0069] As the polyisocyanate derivative, from the viewpoint of light resistance, preferably, a polyisocyanate derivative derived from an aliphatic polyisocyanate (hereinafter, referred to as an aliphatic polyisocyanate derivative) and a polyisocyanate derivative derived from an aromatic aliphatic polyisocyanate (hereinafter, referred to as an aromatic aliphatic polyisocyanate derivative) are used.
[0070] As the polyisocyanate derivative, from the viewpoint of achieving a balance between antibacterial properties, storage stability, curing properties and light resistance, an aromatic aliphatic polyisocyanate derivative is more preferred.
[0071] In other words, the polyisocyanate (a) preferably contains an araliphatic polyisocyanate derivative. As the araliphatic polyisocyanate derivative, preferably, a derivative of xylylene diisocyanate is used, and more preferably, an isocyanurate modified product of xylylene diisocyanate is used.
[0072] The average number of isocyanate groups in the polyisocyanate (a) is, for example, 2 or more, or preferably 2.5 or more. The average number of isocyanate groups in the polyisocyanate (a) is, for example, 4 or less, or preferably 3.5 or less.
[0073] The polyisocyanate (a) has an isocyanate group content (NCO%) of, for example, 5 mass% or more, preferably 7 mass% or more. The polyisocyanate (a) has an isocyanate group content (NCO%) of, for example, 30 mass% or less, preferably 25 mass% or less.
[0074] (3) Antibacterial-non-blocking sealant (b) The antibacterial non-blocking sealing agent (b) is a raw material compound for forming the antibacterial non-blocking sealing group (B). The antibacterial non-blocking sealing agent (b) reacts with at least a portion of the isocyanate groups of the polyisocyanate (a) to form the antibacterial non-blocking sealing group (B).
[0075] The antibacterial non-blocking sealant (b) contains one or more active hydrogen groups per molecule and one or more antibacterial groups per molecule.
[0076] The active hydrogen group is a functional group (non-blocking group) that is bonded to the isocyanate group in an irremovable manner. Examples of the active hydrogen group include a hydroxyl group, an amino group, and a mercapto group, and preferably a hydroxyl group. The number of active hydrogen groups is preferably one per molecule of the antibacterial non-blocking sealant (b).
[0077] The antibacterial group is a functional group that exhibits antibacterial properties. Examples of the antibacterial group include the above-mentioned quaternary ammonium group. The number of antibacterial groups is preferably one per molecule of the antibacterial non-blocking sealant (b).
[0078] More specifically, the antibacterial non-blocking sealant (b) may be a quaternary ammonium group-containing compound. The quaternary ammonium group-containing compound is, for example, a compound having one active hydrogen group and one quaternary ammonium group in one molecule. More specifically, the quaternary ammonium group-containing compound may be a trialkyl alkanol ammonium compound.
[0079] Examples of trialkylalkanol ammonium compounds include choline chloride, choline bromide, choline iodide, choline acetate, choline carbonate, choline phosphate, choline hydroxide, choline citrate, choline tartrate, choline bitartrate, and choline lactate. These can be used alone or in combination of two or more.
[0080] From the viewpoint of storage stability, choline bromide and choline acetate are preferred, and from the viewpoint of low cost, choline chloride is preferred.
[0081] In the raw material components, the proportion of the antibacterial non-blocking sealing agent (b) is, for example, 5 mols or more, preferably 10 mols or more, more preferably 15 mols or more, relative to 100 mols of isocyanate groups in the polyisocyanate (a), from the viewpoints of antibacterial activity, water dispersibility and storage stability. The proportion of the antibacterial non-blocking sealing agent (b) is, for example, 80 mols or less, preferably 60 mols or less, relative to 100 mols of isocyanate groups in the polyisocyanate (a), from the viewpoints of durability, and more preferably 40 mols or less, even more preferably 30 mols or less, particularly preferably 25 mols or less, relative to 100 mols of isocyanate groups in the polyisocyanate (a), from the viewpoints of water dispersibility and storage stability.
[0082] In addition, the ratio of the antibacterial non-blocking sealing agent (b) in the raw material components is, for example, 2.0 parts by mass or more, preferably 4.5 parts by mass or more, more preferably 6.0 parts by mass or more, based on 100 parts by mass of the polyisocyanate (a), from the viewpoints of antibacterial activity, water dispersibility, and storage stability. In addition, the ratio of the antibacterial non-blocking sealing agent (b) is, for example, 20.0 parts by mass or less, preferably 15.0 parts by mass or less, more preferably 12.5 parts by mass or less, based on 100 parts by mass of the polyisocyanate (a), from the viewpoints of antibacterial activity, water dispersibility, and storage stability.
[0083] (4) Non antibacterial - Block sealant (c) The non-antibacterial blocked sealing agent (c) is a raw material compound for forming the non-antibacterial blocked sealing group (C). The non-antibacterial blocked sealing agent (c) reacts with at least a portion of the isocyanate groups of the polyisocyanate (a) to form the non-antibacterial blocked sealing group (C).
[0084] The non-antimicrobial blocking agent (c) is a blocking agent containing one or more blocking groups in one molecule.
[0085] The blocking group is a functional group that blocks and inactivates the isocyanate group of the polyisocyanate (a). The reaction of the blocking group with the isocyanate group forms a latent isocyanate group.
[0086] Examples of the blocking group include guanidine group, imidazole group, alcohol group, phenol group, active methylene group, amine group, imine group, oxime group, carbamic acid group, urea group, acid amide group, acid imide group, triazole group, pyrazole group, mercaptan group, bisulfite, imidazoline group, and pyrimidine group. These can be used alone or in combination of two or more. The number of blocking groups is preferably one for one molecule of antibacterial non-blocking sealant (b).
[0087] More specifically, the non-antibacterial blocking agent (c) may be a known blocking agent (excluding the tertiary amine-containing compound (d1) described later; the same applies below).
[0088] More specific examples of the non-antibacterial blocking sealant (c) include imidazole compounds, alcohol compounds, phenol compounds, active methylene compounds, primary and secondary amine compounds, imine compounds, oxime compounds, carbamic acid compounds, urea compounds, acid amide compounds, acid imide compounds, triazole compounds, pyrazole compounds, mercaptan compounds, bisulfites, imidazoline compounds, and pyrimidine compounds.
[0089] Examples of imidazole compounds include imidazole (IMZ), benzimidazole, 2-methylimidazole, 4-methylimidazole, 2-ethylimidazole, 2-isopropylimidazole, 2,4-dimethylimidazole, 2-ethyl-4-methylimidazole, and 2-amine-imidazole.
[0090] Examples of alcohol compounds include methanol, ethanol, 2-propanol, n-butanol, s-butanol, 2-ethylhexyl alcohol, 1-octanol, 2-octanol, cyclohexyl alcohol, ethylene glycol, benzyl alcohol, 2,2,2-trifluoroethanol, 2,2,2-trichloroethanol, 2-(hydroxymethyl)furan, 2-methoxyethanol, methoxypropanol, 2-ethoxyethanol, n-propoxyethanol, 2-butoxyethanol, 2-ethoxyethoxy Examples of suitable ethanol include ethanol, 2-ethoxybutoxyethanol, butoxyethoxyethanol, 2-butoxyethylethanol, 2-butoxyethoxyethanol, N,N-dibutyl-2-hydroxyacetamide, N-hydroxysuccinimide, N-morpholineethanol, 2,2-dimethyl-1,3-dioxolane-4-methanol, 3-oxazolidineethanol, 2-hydroxymethylpyridine, furfuryl alcohol, 12-hydroxystearic acid, triphenylsilanol, and 2-hydroxyethyl methacrylate.
[0091] Examples of phenolic compounds include phenol, cresol, ethylphenol, n-propylphenol, isopropylphenol, n-butylphenol, s-butylphenol, t-butylphenol, n-hexylphenol, 2-ethylhexylphenol, n-octylphenol, n-nonylphenol, di-n-propylphenol, diisopropylphenol, isopropylcresol, di-n-butylphenol, di-s-butylphenol, di-t-butylphenol, di-n-octylphenol, di-2-ethylhexylphenol, di-n-nonyl Examples of suitable phenols include phenol, nitrophenol, bromophenol, chlorophenol, fluorophenol, dimethylphenol, styrenated phenol, methyl salicylate, methyl 4-hydroxybenzoate, benzyl 4-hydroxybenzoate, 2-ethylhexyl hydroxybenzoate, 4-[(dimethylamino)methyl]phenol, 4-[(dimethylamino)methyl]nonylphenol, bis(4-hydroxyphenyl)acetic acid, 2-hydroxypyridine, 2-hydroxyquinoline, 8-hydroxyquinoline, 2-chloro-3-pyridinol, and pyridine-2-thiol.
[0092] Examples of active methylene compounds include Meldrum's acid, dialkyl malonate, alkyl acetoacetate, 2-acetoacetoxyethyl methacrylate, acetylacetone, and ethyl cyanoacetate. Examples of dialkyl malonate include dimethyl malonate, diethyl malonate, diphenyl malonate, and diphenyl methacrylate. - n-Butyl, di-t-butyl malonate, di-malonate -Examples of the alkyl acetoacetate include 2-ethylhexyl, methyl n-butyl malonate, ethyl n-butyl malonate, methyl s-butyl malonate, ethyl s-butyl malonate, methyl t-butyl malonate, ethyl t-butyl malonate, diethyl methylmalonate, dibenzyl malonate, diphenyl malonate, benzyl methyl malonate, ethyl phenyl malonate, t-butyl phenyl malonate, and isopropylidene malonate. Examples of the alkyl acetoacetate include methyl acetoacetate, ethyl acetoacetate, n-propyl acetoacetate, isopropyl acetoacetate, n-butyl acetoacetate, t-butyl acetoacetate, benzyl acetoacetate, and phenyl acetoacetate.
[0093] Examples of primary and secondary amine compounds include dibutylamine, diphenylamine, aniline, N-methylaniline, carbazole, bis(2,2,6,6-tetramethylpiperidinyl)amine, di-n-propylamine, diisopropylamine (DiPA), isopropylethylamine, 2,2,4-trimethylhexamethyleneamine, 2,2,5-trimethylhexamethyleneamine, N-isopropylcyclohexylamine, dicyclohexylamine, bis(3,5,5-trimethylcyclohexyl )amine, piperidine, 2,6-dimethylpiperidine, t-butylmethylamine, t-butylethylamine, t-butylpropylamine, t-butylbutylamine, t-butylbenzylamine, t-butylphenylamine, 2,2,6-trimethylpiperidine, 2,2,6,6-tetramethylpiperidine, (dimethylamino)-2,2,6,6-tetramethylpiperidine, 2,2,6,6-tetramethyl-4-piperidine, 6-methyl-2-piperidine, and 6-aminocaproic acid.
[0094] Examples of imine compounds include ethyleneimine, polyethyleneimine, and 1,4,5,6-tetrahydropyrimidine.
[0095] Examples of oxime compounds include formaldoxime, acetaldoxime, acetoxime, methyl ethyl ketoxime (MEKO), cyclohexanone oxime, diacetyl monoxime, B Examples of oxime include benzophenone oxime, 2,2,6,6-tetramethylcyclohexanone oxime, diisopropyl ketone oxime, methyl t-butyl ketone oxime, diisobutyl ketone oxime, methyl isobutyl ketone oxime, methyl isopropyl ketone oxime, methyl 2,4-dimethylpentyl ketone oxime, methyl 3-ethylheptyl ketone oxime, methyl isoamyl ketone oxime, n-amyl ketone oxime, 2,2,4,4-tetramethyl-1,3-cyclobutanedione monoxime, 4,4'-dimethoxybenzophenone oxime, and 2-heptanone oxime.
[0096] An example of the carbamic acid compound is N-phenylcarbamate phenyl.
[0097] Urea-based compounds include, for example, urea, thiourea, and ethyleneurea.
[0098] In other words, the acid amide compound is a lactam compound. Examples of the acid amide compound include acetanilide, N-methylacetamide, acetic acid amide, ε-caprolactam, δ-valerolactam, γ-butyrolactam, pyrrolidone, 2,5-piperazinedione, and laurolactam.
[0099] Examples of the acid imide compounds include succinimide, maleimide, and phthalimide.
[0100] Examples of triazole compounds include 1,2,4-triazole and benzotriazole.
[0101] Examples of pyrazole compounds include pyrazole, 3-methylpyrazole, 3-methyl-5-phenylpyrazole, 3,5-diphenylpyrazole, 4-benzyl-3,5-dimethylpyrazole, 4-nitro-3,5-dimethylpyrazole, 4-bromo-3,5-dimethylpyrazole, and 3,5-dialkylpyrazole. 3,5-dialkylpyrazole does not have a substituent at the 4-position of the pyrazole ring. Examples of 3,5-dialkylpyrazole include 3,5-dimethylpyrazole (DMP), 3,5-diisopropylpyrazole, and 3,5-di-t-butylpyrazole.
[0102] Examples of mercaptan compounds include butyl mercaptan, dodecyl mercaptan, and hexyl mercaptan.
[0103] An example of the bisulfite is sodium bisulfite.
[0104] Examples of the imidazoline compounds include 2-methylimidazoline and 2-phenylimidazoline.
[0105] An example of the pyrimidine compound is 2-methyl-1,4,5,6-tetrahydropyrimidine.
[0106] Non-antimicrobial blocking sealants (c) also include, for example, benzoxazolones, isatoic anhydride, and tetrabutylphosphonium acetate.
[0107] These can be used alone or in combination of two or more kinds. The non-antibacterial blocking sealant (c) preferably contains a pyrazole-based compound, more preferably consists of a pyrazole-based compound. As the pyrazole-based compound, preferably, 3,5-diphenylpyrazole and 3,5-dialkylpyrazole are included, more preferably, 3,5-dialkylpyrazole are included, and further preferably, 3,5-dimethylpyrazole (DMP) is included.
[0108] In the raw material components, the ratio of the non-antibacterial blocking agent (c) to 100 moles of isocyanate groups of the polyisocyanate (a) is, from the viewpoint of durability, for example, 20 moles or more, preferably 40 moles or more, and from the viewpoints of water dispersibility and storage stability, more preferably 60 moles or more, even more preferably 70 moles or more, particularly preferably 75 moles or more. Also, the ratio of the non-antibacterial blocking agent (c) to 100 moles of isocyanate groups of the polyisocyanate (a) is, from the viewpoints of antibacterial property, water dispersibility and storage stability, for example, 95 moles or less, preferably 90 moles or less, more preferably 85 moles or less.
[0109] In addition, the ratio of the non-antibacterial blocking agent (c) in the raw material components is, from the viewpoints of antibacterial activity, water dispersibility and storage stability, for example, 18.0 parts by mass or more, preferably 22.0 parts by mass or more, more preferably 25.0 parts by mass or more, per 100 parts by mass of the polyisocyanate (a). In addition, the ratio of the non-antibacterial blocking agent (c) is, from the viewpoints of antibacterial activity, water dispersibility and storage stability, for example, 33.0 parts by mass or less, preferably 30.0 parts by mass or less, more preferably 27.0 parts by mass or less, per 100 parts by mass of the polyisocyanate (a).
[0110] (5) Antibacterial block capping group forming material (d) The raw material components may further contain a raw material compound (d) for forming the antibacterial block capping group (D) (hereinafter, referred to as antibacterial block capping group-forming raw material).
[0111] The antibacterial blocking group forming raw material (d) contains, for example, a tertiary amino group-containing compound (d1) and an acid (d2).
[0112] The tertiary amino group-containing compound (d1) is a raw material compound for adding a tertiary amino group to the blocked isocyanate. The tertiary amino group-containing compound (d1) reacts with at least a part of the isocyanate groups of the polyisocyanate (a) to add a tertiary amino group to the polyisocyanate (a).
[0113] The tertiary amino group-containing compound (d1) contains, for example, one or more of the above-mentioned blocking groups in one molecule and one or more of the above-mentioned tertiary amino groups in one molecule.
[0114] More specifically, the tertiary amino group-containing compound includes a guanidine compound represented by the following general formula (1). [ka] (In the formula, R 1 ~R 5 represents a hydrocarbon group having 1 to 12 carbon atoms or a hydrogen atom. 1 and R 2 and R both represent a hydrocarbon group having 1 to 12 carbon atoms, and / or 4 and R 5 Both R and R represent a hydrocarbon group having 1 to 12 carbon atoms. 1 and R 3 may be bonded to each other to form a heterocycle. 4 and R 1 may be bonded to each other to form a heterocycle. 5 and R 3 may be bonded to each other to form a heterocycle. In the above general formula (1), R 1 ~R 5 may be the same or different. 1 ~R 5 represents a hydrocarbon group having 1 to 12 carbon atoms or a hydrogen atom.
[0115] However, R 1 and R 2 and R both represent a hydrocarbon group having 1 to 12 carbon atoms, and / or 4 and R 5 and both represent a hydrocarbon group having 1 to 12 carbon atoms. As a result, the guanidine compound represented by the general formula (1) contains at least one tertiary amino group.
[0116] R 1 ~R 5Examples of the hydrocarbon group having 1 to 12 carbon atoms include an alkyl group having 1 to 12 carbon atoms and an aryl group having 6 to 12 carbon atoms.
[0117] Examples of the alkyl group having 1 to 12 carbon atoms include linear alkyl groups having 1 to 12 carbon atoms and cyclic alkyl groups having 3 to 12 carbon atoms.
[0118] Examples of the chain alkyl group having 1 to 12 carbon atoms include linear or branched chain alkyl groups having 1 to 12 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, tert-pentyl, hexyl, heptyl, octyl, nonyl, isononyl, decyl, undecyl, and dodecyl.
[0119] Examples of the cyclic alkyl group having 3 to 12 carbon atoms include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, and cyclododecyl.
[0120] Examples of the aryl group having 6 to 12 carbon atoms include phenyl, tolyl, xylyl, naphthyl, azulenyl, and biphenyl.
[0121] The hydrocarbon group having 1 to 12 carbon atoms is R 1 ~R 5 In these, they may be the same or different from each other.
[0122] Also, R 1 and R 3 can be bonded to each other to form a heterocycle.
[0123] R 1 and R 3The heterocycle formed by bonding to each other is a nitrogen-containing heterocycle having a -N=CN- structure, and examples thereof include a 3- to 20-membered heterocycle, preferably a 3- to 10-membered heterocycle, more preferably a 3- to 8-membered heterocycle, and further preferably a 5- to 7-membered heterocycle. The heterocycle may be, for example, a monocyclic ring, or a polycyclic ring in which a plurality of monocyclic rings share one side. The heterocycle may be a conjugated heterocycle.
[0124] Also, R 4 and R 1 can be bonded together to form a heterocycle. 5 and R 3 can be bonded to each other to form a heterocycle.
[0125] Also, R 1 , R 3 , R 4 and R 5 The heterocycle formed from may be a polycycle in which a plurality of monocycles share one side. In this case, the heterocycle formed is a nitrogen-containing heterocycle having a -N=CN- structure, and examples thereof include a 6- to 20-membered heterocycle, preferably a 6- to 15-membered heterocycle, more preferably a 6- to 12-membered heterocycle, and further preferably a 10- to 12-membered heterocycle. The heterocycle may also be a conjugated heterocycle. In addition, R 1 , R 3 , R 4 and R 5 When R forms a heterocycle, 2 preferably represents a hydrogen atom. Specific examples of such heterocyclic structures include triazabicyclo ring structures.
[0126] In the above general formula (1), R 1 ~R 5 preferably represents a hydrocarbon group having 1 to 12 carbon atoms or a hydrogen atom, more preferably represents an alkyl group having 1 to 12 carbon atoms or a hydrogen atom, and even more preferably represents a chain alkyl group having 1 to 12 carbon atoms or a hydrogen atom.
[0127] However, R 1and R 2 and R both represent a hydrocarbon group having 1 to 12 carbon atoms, and / or 4 and R 5 Both of and represent a hydrocarbon group having 1 to 12 carbon atoms.
[0128] Particularly preferably, in the above general formula (1), R 1 , R 2 , R 4 and R 5 represents a chain alkyl group having 1 to 12 carbon atoms, and R 3 represents a hydrogen atom.
[0129] Specific examples of the guanidine compound represented by the above general formula (1) include 3,3-dialkylguanidine, 1,1,3,3-tetraalkylguanidine, and 1,5,7-triazabicyclo[4.4.0]dec-5-ene.
[0130] The guanidine compounds represented by the above general formula (1) can be used alone or in combination of two or more kinds.
[0131] Tertiary amino group-containing compound (d1) is not limited to the above guanidine compound. Tertiary amino group-containing compound (d1) includes, in addition to the above guanidine compound, for example, N-dimethylaminoethanol (DMAE), N-methyldiethanolamine (MDEA), N-methylpiperazine (MPZ), N-methylhomopiperazine (MHPZ), 1,8-diazabicyclo[5.4.0]-7-undecene (DBU), N,N,N'-trimethylethylenediamine (TMEDA) and 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TABD).
[0132] The tertiary amino group-containing compound (d1) can be used alone or in combination of two or more kinds. From the viewpoint of antibacterial properties and water dispersibility, the tertiary amino group-containing compound (d1) is preferably a guanidine compound represented by the above general formula (1), more preferably 1,1,3,3-tetraalkylguanidine, and more preferably 1,1,3,3-tetramethylguanidine (TMG).
[0133] In the raw material components, the ratio of the tertiary amino group-containing compound (d1) is, for example, 0.1 mol or more, preferably 1 mol or more, based on 100 mol of the isocyanate group of the polyisocyanate (a) from the viewpoints of antibacterial properties, water dispersibility and storage stability. The ratio of the tertiary amino group-containing compound (d1) is, for example, 20 mol or less, preferably 10 mol or less, based on 100 mol of the isocyanate group of the polyisocyanate (a) from the viewpoints of antibacterial properties, water dispersibility and storage stability.
[0134] In addition, the ratio of the tertiary amino group-containing compound (d1) in the raw material components is, for example, 0.1 parts by mass or more, preferably 1.3 parts by mass or more, more preferably 1.5 parts by mass or more, based on 100 parts by mass of the polyisocyanate (a) from the viewpoints of antibacterial properties, water dispersibility and storage stability. In addition, the ratio of the tertiary amino group-containing compound (d1) is, for example, 15.0 parts by mass or less, preferably 12.0 parts by mass or less, more preferably 10.0 parts by mass or less, based on 100 parts by mass of the polyisocyanate (a) from the viewpoints of antibacterial properties, water dispersibility and storage stability.
[0135] The acid (d2) is a raw material compound for neutralizing at least a part of the tertiary amino group to form a tertiary ammonium salt. The acid (d2) is not particularly limited as long as it can neutralize the tertiary amino group, and examples thereof include the acids described above as the antibacterial blocking group (D). The acid (d2) is preferably acetic acid, propionic acid, and lactic acid, and more preferably acetic acid.
[0136] In the raw material components, the ratio of the acid (d2) is, for example, 0.5 equivalents or more, preferably 0.8 equivalents or more, relative to the tertiary amino group of the tertiary amino group-containing compound (d1). The ratio of the acid (d2) is, for example, 5.0 equivalents or less, preferably 3.0 equivalents or less, relative to 100 moles of the tertiary amino group of the tertiary amino group-containing compound (d1).
[0137] (6) Hydrophilic compound (e) The raw material components may further contain a hydrophilic compound (e) for forming the hydrophilic group (E).
[0138] The hydrophilic compound (e) has an active hydrogen group and a hydrophilic group. For example, the hydrophilic compound (e) may be a nonionic hydrophilic compound, preferably a polyoxyethylene compound. The polyoxyethylene compound has at least three consecutive oxyethylene groups.
[0139] Examples of the polyoxyethylene compound include polyoxyethylene group-containing polyols, polyoxyethylene group-containing polyamines, one-end-capped polyoxyethylene glycols, and one-end-capped polyoxyethylene diamines.
[0140] The polyoxyethylene compounds can be used alone or in combination of two or more kinds.
[0141] The polyoxyethylene compound preferably includes one-end-blocked polyoxyethylene glycol, and more preferably includes monoalkoxypolyoxyethylene glycol.
[0142] One end of the monoalkoxypolyoxyethylene glycol is capped, for example, with an alkyl group having 1 to 20 carbon atoms, preferably with an alkyl group having 1 to 4 carbon atoms. A hydroxyl group is located at the other end of the monoalkoxypolyoxyethylene glycol.
[0143] Examples of monoalkoxypolyoxyethylene glycol include methoxypolyoxyethylene glycol (MeOPEG) and ethoxypolyoxyethylene glycol, and preferably methoxypolyoxyethylene glycol.
[0144] In the polyoxyethylene compound, the number of repeating oxyethylene units is, for example, 3 or more, preferably 5 or more. In addition, the number of repeating oxyethylene units is, for example, 100 or less, preferably 50 or less.
[0145] The number average molecular weight of the polyoxyethylene compound is, for example, 200 or more, preferably 400 or more. The number average molecular weight of the polyoxyethylene compound is, for example, 2000 or less, preferably 1500 or less. The number average molecular weight of the polyoxyethylene compound can be measured by gel permeation chromatography.
[0146] In the raw material components, the ratio of the hydrophilic compound (e) is, for example, 0.1 mol or more, preferably 1 mol or more, based on 100 mol of isocyanate groups of the polyisocyanate (a) from the viewpoints of antibacterial properties, water dispersibility and storage stability. The ratio of the hydrophilic compound (e) is, for example, 20 mol or less, preferably 10 mol or less, based on 100 mol of isocyanate groups of the polyisocyanate (a) from the viewpoints of antibacterial properties, water dispersibility and storage stability.
[0147] In addition, in the raw material components, the ratio of the hydrophilic compound (e) is, for example, 0.1 parts by mass or more, preferably 1.0 parts by mass or more, and more preferably 1.5 parts by mass or more, per 100 parts by mass of the polyisocyanate (a), from the viewpoints of antibacterial properties, water dispersibility, and storage stability. In addition, the ratio of the hydrophilic compound (e) is, for example, 65.0 parts by mass or less, preferably 32.0 parts by mass or less, and more preferably 30.0 parts by mass or less, per 100 parts by mass of the polyisocyanate (a), from the viewpoints of antibacterial property, water dispersibility, and storage stability.
[0148] (7) Reaction of raw material components In the reaction of the raw material components, the above-mentioned components may be reacted simultaneously, or the above-mentioned components may be reacted sequentially.
[0149] Preferably, first, the polyisocyanate (a) and the antibacterial non-blocking sealant (b) are mixed in the above-mentioned ratio and reacted (first reaction step).
[0150] The reaction environment of the first reaction step is, for example, an inert gas atmosphere. Examples of the inert gas include nitrogen gas and argon gas. The reaction pressure of the first reaction step is, for example, a pressurized condition or an atmospheric pressure condition, and is preferably an atmospheric pressure condition.
[0151] The reaction temperature in the first reaction step is, for example, 40° C. or more, preferably 50° C. or more. The reaction temperature in the first reaction step is, for example, 100° C. or less, preferably 80° C. or less. The reaction time in the first reaction step is, for example, 0.5 hours or more, preferably 1.0 hour or more. The reaction time in the first reaction step is, for example, 24 hours or less, preferably 12 hours or less.
[0152] The progress of the reaction can be determined, for example, by confirming the disappearance or reduction of isocyanate groups using infrared spectroscopy, etc. Alternatively, the progress of the reaction can be determined, for example, by measuring the isocyanate group content using a known titration method and confirming the reduction in the isocyanate group content.
[0153] As a result, a portion of the isocyanate groups of the polyisocyanate (a) is blocked by the antibacterial non-blocking blocking agent (b) so as to be irreproducible. As a result, antibacterial non-blocking blocking groups (B) are formed. In addition, a portion of the isocyanate groups of the polyisocyanate (a) (the remainder of the above portion) is not blocked by the antibacterial non-blocking blocking agent (b) and remains in a free state.
[0154] That is, in the primary reaction step, a reaction product (primary reaction product) having antibacterial non-blocked capping groups (B) and free isocyanate groups is obtained.
[0155] Next, in this method, the primary reaction product and the non-antibacterial blocking sealant (c) are mixed in the above-mentioned ratio and reacted (secondary reaction step).
[0156] The reaction environment of the secondary reaction step is, for example, an inert gas atmosphere. Examples of the inert gas include nitrogen gas and argon gas. The reaction pressure of the secondary reaction step is, for example, a pressurized condition or an atmospheric pressure condition, and is preferably an atmospheric pressure condition.
[0157] The reaction temperature in the secondary reaction step is, for example, 0° C. or higher, preferably 20° C. or higher. The reaction temperature in the secondary reaction step is, for example, 80° C. or lower, preferably 60° C. or lower. The reaction time in the secondary reaction step is, for example, 0.5 hours or higher, preferably 1.0 hour or higher. The reaction time in the secondary reaction step is, for example, 24 hours or lower, preferably 12 hours or lower.
[0158] The completion of the reaction can be determined by, for example, infrared spectroscopy, etc., and by confirming the disappearance or reduction of isocyanate groups.
[0159] This reproducibly caps the free isocyanate groups of the primary reaction product with the non-antimicrobial-blocked capping agent (c), thereby forming the non-antimicrobial-blocked capping group (C).
[0160] In the above-mentioned primary reaction step and secondary reaction step, the isocyanate groups of the polyisocyanate (a) are blocked with the antibacterial non-blocked blocking group (B) and the non-antibacterial blocked blocking group (C), thereby forming a blocked residue of the polyisocyanate (A).
[0161] That is, in the secondary reaction step, a blocked isocyanate (secondary reaction product) is obtained which comprises a blocking residue of polyisocyanate (A), an antibacterial non-blocked blocking group (B), and a non-antibacterial blocked blocking group (C).
[0162] Such blocked isocyanates include a blocking residue of polyisocyanate (A), an antibacterial non-blocked blocking group (B), and a non-antibacterial blocked blocking group (C). The antibacterial non-blocked blocking group (B) contains a quaternary ammonium group. Therefore, the blocked isocyanates have excellent antibacterial properties and can be fixed in a resin with a relatively high degree of freedom.
[0163] (8) Quaternary treatment In the above method, the antibacterial-unblocked capping group (B) is formed by reacting the polyisocyanate (a) with the antibacterial-unblocked capping agent (b). However, for example, the antibacterial-unblocked capping group (B) may be formed without using the antibacterial-unblocked capping agent (b).
[0164] More specifically, the antibacterial non-blocking capping group (B) may be formed without using a quaternary ammonium group-containing compound, for example, by using a tertiary amino group-containing compound and subjecting the tertiary amino group to a quaternary treatment.
[0165] In such a case, for example, in the above-mentioned primary reaction step, a tertiary amine-containing compound (b1) is added in place of the antibacterial non-blocking sealant (b) (e.g., a quaternary ammonium group-containing compound), and these are reacted (primary reaction step).
[0166] Examples of the tertiary amine-containing compound (b1) include the tertiary amine-containing compounds described above as the raw material for forming the antibacterial blocking group. These can be used alone or in combination of two or more kinds.
[0167] The mixing ratio of the tertiary amine-containing compound (d1) is based on the mixing ratio of the antibacterial non-blocking sealant (b) described above. The reaction conditions in the primary reaction step are the same as those described above. This results in a reaction product (primary reaction product) having a tertiary amino group and a free isocyanate group.
[0168] Next, in this method, the primary reaction product and the antibacterial-blocking sealing agent (c) are mixed in the above ratio and reacted (secondary reaction step), as in the above, to obtain a reaction product (secondary reaction product) having a polyisocyanate blocking residue (A), a non-antibacterial-blocking sealing group (C), and a tertiary amino group.
[0169] In this method, the tertiary amino groups of the secondary reaction product are then subjected to a quaternization treatment by a known method (quaternization treatment step).
[0170] In the quaternization process, for example, a tertiary amino group is reacted with a quaternization agent (b2). Examples of the quaternization agent (b2) include methyl chloride, allyl chloride, benzyl chloride, dimethyl sulfate, dimethyl carbonate, propylene oxide, butylene oxide, styrene oxide, epibromohydrin, ethylene chlorohydrin, 3-chloro-1,2-propanediol, 3-chloro-2-hydroxypropyltrimethylammonium chloride, glycidyltrimethylammonium chloride, glycidol, butyl glycidyl ether, allyl glycidyl ether, and glycidyl methacrylate. These can be used alone or in combination of two or more kinds. As the quaternization agent (b2), methyl chloride is preferably used.
[0171] The ratio of the quaternizing agent (b2) is, for example, 0.5 equivalents or more, preferably 0.8 equivalents or more, relative to the tertiary amino group of the tertiary amino group-containing compound (b1). The ratio of the quaternizing agent (b2) is, for example, 5.0 equivalents or less, preferably 3.0 equivalents or less, relative to 100 moles of the tertiary amino group of the tertiary amino group-containing compound (b1).
[0172] The reaction environment of the quaternization process is, for example, an inert gas atmosphere. Examples of the inert gas include nitrogen gas and argon gas. The reaction pressure of the quaternization process is, for example, pressurized conditions and atmospheric conditions, and preferably atmospheric conditions.
[0173] The reaction temperature of the quaternization treatment step is, for example, 0° C. or higher, preferably 20° C. or higher. The reaction temperature of the quaternization treatment step is, for example, 80° C. or lower, preferably 60° C. or lower. The reaction time of the quaternization treatment step is, for example, 0.5 hours or higher, preferably 1.0 hours or higher. The reaction time of the quaternization treatment step is, for example, 24 hours or lower, preferably 12 hours or lower.
[0174] This causes the tertiary amino group to be quaternized, forming a quaternary ammonium group (antibacterial non-blocked blocking group (B)). As a result, a blocked isocyanate (quaternized product) is obtained that comprises the blocking residue (A) of polyisocyanate, the antibacterial non-blocked blocking group (B), and the non-antibacterial blocked blocking group (C).
[0175] Such quaternary treatment products teeth The blocked isocyanate comprises a blocking residue (A) of a polyisocyanate, an antibacterial non-blocked blocking group (B), and a non-antibacterial blocked blocking group (C). The antibacterial non-blocked blocking group (B) contains a quaternary ammonium group. Therefore, the blocked isocyanate has excellent antibacterial properties and can be fixed in a resin with a relatively high degree of freedom.
[0176] On the other hand, from the viewpoint of obtaining particularly excellent antibacterial properties, preferably, a blocked isocyanate that has not been quaternized is used, and more specifically, a reaction product of raw material components including a polyisocyanate (a), an antibacterial non-blocking sealant (b), and a non-antibacterial blocking sealant (c) is used.
[0177] (9) Reaction of antibacterial block capping group forming raw material (d) The raw material components may contain an antibacterial block capping group forming raw material (d). In such a case, if necessary, a tertiary amino group-containing compound (d1) is mixed in the above ratio in the first reaction step and / or the second reaction step. Preferably, in the second reaction step, a tertiary amino group-containing compound (d1) is mixed in the above ratio together with the non-antibacterial block capping agent (c).
[0178] In the secondary reaction step, when the tertiary amino group-containing compound (d1) is added, at least a part of the free isocyanate groups in the primary reaction product are blocked reproducibly with the non-antibacterial blocking agent (c). Also, at least a part of the free isocyanate groups in the primary reaction product are blocked with the tertiary amino group-containing compound (d1).
[0179] As a result, a secondary reaction product is obtained that contains a non-antibacterial blocked sealing group (C) derived from the non-antibacterial blocked sealing agent (c) and a tertiary amino group derived from the tertiary amino group-containing compound (d1).
[0180] In such a case, after the above-mentioned secondary reaction step, the acid (d2) is added to the secondary reaction product in the above-mentioned ratio and reacted with the secondary reaction product, whereby at least a part of the tertiary amino groups is neutralized with the acid to form a tertiary ammonium salt (neutralization step).
[0181] The reaction environment of the neutralization step is, for example, an inert gas atmosphere. Examples of the inert gas include nitrogen gas and argon gas. The reaction pressure of the neutralization step is, for example, a pressurized condition or an atmospheric pressure condition, and is preferably an atmospheric pressure condition.
[0182] The reaction temperature in the neutralization step is, for example, 0° C. or higher, preferably 20° C. or higher. The reaction temperature in the neutralization step is, for example, 80° C. or lower, preferably 60° C. or lower. The reaction time in the neutralization step is, for example, 0.5 hours or higher, preferably 1.0 hours or higher. The reaction time in the neutralization step is, for example, 24 hours or lower, preferably 12 hours or lower.
[0183] This results in the tertiary amino group being neutralized by the acid, forming an antibacterial-blocking capping group (D) containing a tertiary ammonium salt.
[0184] That is, the above method produces a blocked isocyanate (neutralization reaction product) comprising a blocking residue of polyisocyanate (A), an antibacterial non-blocking blocking group (B), a non-antibacterial blocked blocking group (C), and an antibacterial blocked blocking group (D).
[0185] Such blocked isocyanates comprise a polyisocyanate blocking residue (A), an antibacterial non-blocked blocking group (B), a non-antibacterial blocked blocking group (C), and further comprise an antibacterial blocked blocking group (D), and therefore have particularly excellent antibacterial properties and curing properties.
[0186] (10) Reaction of hydrophilic compound (e) The raw material components may contain a hydrophilic compound (e). In such a case, the hydrophilic compound (e) is mixed in the above ratio in the first reaction step and / or the second reaction step, as necessary. Preferably, the hydrophilic compound (e) is mixed in the above ratio together with the antibacterial non-blocking sealant (b) in the first reaction step.
[0187] In the first reaction step, when the hydrophilic compound (e) is blended, at least a part of the free isocyanate groups of the polyisocyanate compound (a) is irreproducibly blocked by the antibacterial non-blocking blocking agent (b). Also, at least a part of the free isocyanate groups of the polyisocyanate compound (a) is irreproducibly blocked by the hydrophilic compound (e).
[0188] The result is a primary reaction product containing antimicrobial-nonblocked capping groups (B) derived from the antimicrobial-nonblocked capping agent (b) and hydrophilic groups (E) derived from the hydrophilic compound (e).
[0189] Thereafter, as described above, the primary reaction product is reacted with the non-antibacterial-blocking sealant (c) to obtain a secondary reaction product (secondary reaction step).
[0190] This results in a blocked isocyanate (secondary reaction product) having a blocking residue of polyisocyanate (A), an antibacterial non-blocking blocking group (B), a non-antibacterial blocked blocking group (C), and a hydrophilic group (E).
[0191] Such blocked isocyanates include a polyisocyanate blocking residue (A), an antibacterial non-blocked blocking group (B), a non-antibacterial blocked blocking group (C), and further include a hydrophilic group (E), and therefore have particularly excellent water dispersibility.
[0192] (11) Reaction of antibacterial block capping group forming material (d) and hydrophilic compound (e) The raw material components may include an antibacterial block capping group forming raw material (d) and a hydrophilic compound (e). In such a case, preferably, in the first reaction step, the hydrophilic compound (e) is mixed with the antibacterial non-blocking capping agent (b) in the above ratio. Also, preferably, in the second reaction step, the tertiary amino group-containing compound (d1) is mixed with the non-antibacterial block capping agent (c) in the above ratio. Also, similarly to the above, the secondary reaction product is neutralized with an acid (d2).
[0193] This results in a blocked isocyanate (neutralization reaction product) comprising a blocking residue of polyisocyanate (A), an antibacterial non-blocking blocking group (B), a non-antibacterial blocked blocking group (C), an antibacterial blocked blocking group (D), and a hydrophilic group (E).
[0194] Such blocked isocyanates comprise a polyisocyanate blocking residue (A), an antibacterial non-blocked blocking group (B), a non-antibacterial blocked blocking group (C), and further comprise an antibacterial blocked blocking group (D) and a hydrophilic group (E), and therefore have particularly excellent antibacterial properties, curing properties, and water dispersibility.
[0195] In the blocked isocyanate, the content of free isocyanate groups derived from the polyisocyanate (a) is substantially zero.
[0196] In other words, all of the free isocyanate groups derived from the polyisocyanate (a) have reacted with either the antibacterial non-blocking sealing agent (b) or the non-antibacterial blocked sealing agent (c) (and, if necessary, the antibacterial blocked sealing group forming raw material (d) and the hydrophilic compound (e)).
[0197] More specifically, all of the free isocyanate groups derived from the polyisocyanate (a) are preferably reacted with either the antibacterial unblocked capping agent (b) or the non-antibacterial blocked capping agent (c), respectively. This results in all of the free isocyanate groups derived from the polyisocyanate (a) being blocked. The resulting blocked isocyanate comprises the blocking residue of the polyisocyanate (A), the antibacterial unblocked capping group (B), and the non-antibacterial blocked capping group (C).
[0198] In addition, all of the free isocyanate groups derived from the polyisocyanate (a) are preferably reacted with either the antibacterial non-blocking blocking agent (b), the non-antibacterial blocking blocking agent (c), or the antibacterial blocking blocking group forming raw material (d). As a result, all of the free isocyanate groups derived from the polyisocyanate (a) are blocked. The resulting blocked isocyanate comprises the blocking residue (A) of the polyisocyanate, the antibacterial non-blocking blocking group (B), the non-antibacterial blocking blocking group (C), and further comprises the antibacterial blocking blocking group (D).
[0199] In addition, all of the free isocyanate groups derived from the polyisocyanate (a) are preferably reacted with either the antibacterial non-blocking blocking agent (b), the non-antibacterial blocking blocking agent (c), the antibacterial blocking blocking group forming raw material (d), or the hydrophilic compound (e). As a result, all of the free isocyanate groups (free isocyanate groups) derived from the polyisocyanate (a) are blocked. The resulting blocked isocyanate comprises the blocking residue (A) of the polyisocyanate, the antibacterial non-blocking blocking group (B), and the non-antibacterial blocking blocking group (C), and further comprises the antibacterial blocking blocking group (D) and the hydrophilic group (E).
[0200] (12) Other forms The reaction order of the raw material components is not limited to the above. That is, the polyisocyanate (a), the antibacterial non-blocking sealing agent (b), and the non-antibacterial blocking sealing agent (c) can be reacted in any order. In addition, the antibacterial blocking group forming raw material (d) and / or the hydrophilic compound (e) can be mixed and reacted at any timing.
[0201] In addition, each of the above reactions may be carried out without a solvent or, for example, in the presence of an organic solvent. Examples of the organic solvent include ketones and nitriles. 、Examples of the organic solvent include aliphatic hydrocarbons, alicyclic hydrocarbons, aromatic hydrocarbons, glycol ether esters, ethers, halogenated aliphatic hydrocarbons, and polar aprotic solvents. The organic solvents can be used alone or in combination of two or more kinds.
[0202] For example, when the blocked isocyanate is not quaternized, that is, when the polyisocyanate (a) reacts with the antibacterial non-blocking sealant (b) containing a quaternary ammonium group-containing compound, and the non-antibacterial blocked sealant (c), they are preferably reacted in the presence of an organic solvent. As the organic solvent, a hydrophilic solvent capable of dissolving the quaternary ammonium group-containing compound is used. As the hydrophilic solvent, for example, nitriles (e.g., acetonitrile and propionitrile) and polar aprotic solvents (e.g., acetone, N-methylpyrrolidone, dimethylformamide, N,N'-dimethylacetamide, dimethylsulfoxide, and hexamethylphosphonylamide) can be mentioned.
[0203] In any of the above reactions, when an organic solvent is added, for example, a solution of blocked isocyanate is obtained. In such a case, for example, water is added to the blocked isocyanate solution and / or blocked isocyanate dispersion to emulsify the blocked isocyanate, and the emulsion is heated under reduced pressure to obtain the organic solvent This allows the production of an aqueous dispersion of a blocked isocyanate.
[0204] The solid content concentration of the blocked isocyanate solution and / or aqueous dispersion is, for example, 1 mass % or more, preferably 10 mass % or more. The solid content concentration of the blocked isocyanate solution and / or aqueous dispersion is, for example, 80 mass % or less, preferably 50 mass % or less.
[0205] 3.Antibacterial agents The antibacterial agent may contain the above-mentioned blocked isocyanate. For example, the antibacterial agent may be a solid content of the blocked isocyanate. The antibacterial agent may also be a solution and / or an aqueous dispersion of the blocked isocyanate.
[0206] Furthermore, the antibacterial agent may contain additives. Examples of additives include solvents, catalysts, epoxy resins, coating property improvers, leveling agents, defoamers, antioxidants, UV absorbers, thickeners, antisettling agents, plasticizers, surfactants, pigments, fillers, organic fine particles, inorganic fine particles, and antifungal agents. The amount of additives to be added is appropriately determined depending on the purpose and application.
[0207] Furthermore, the antibacterial agent may contain other isocyanate components in addition to the above-mentioned blocked isocyanate (blocked isocyanate having a blocking residue of polyisocyanate (A), an antibacterial non-blocked blocking group (B), and a non-antibacterial blocked blocking group (C). Examples of the other isocyanate components include isocyanates that do not have an antibacterial non-blocked blocking group (B) and / or a non-antibacterial blocked blocking group (C). The content ratio of the other isocyanate components is not particularly limited and is appropriately set depending on the purpose and application.
[0208] The above antibacterial agent may be used in combination with a known antibacterial agent. That is, the above antibacterial agent may be mixed with another antibacterial agent. The mixing ratio is appropriately determined depending on the purpose and application.
[0209] 4. Effects The antibacterial agent includes a blocked isocyanate. The blocked isocyanate includes a blocking residue of a polyisocyanate (A), an antibacterial non-blocked blocking group (B), and a non-antibacterial blocked blocking group (C). The antibacterial non-blocked blocking group (B) includes a quaternary ammonium group. Therefore, the antibacterial agent has excellent antibacterial properties and can be fixed in a resin with a relatively high degree of freedom.
[0210] 5. Resin (1) Hardener A method for immobilizing an antibacterial agent on a resin (substance to be immobilized) will be described in detail below. When an antibacterial agent is immobilized on a resin, the antibacterial agent preferably also serves as a curing agent.
[0211] The average functionality of the isocyanate groups (including free isocyanate groups and latent isocyanate groups) of the curing agent is, for example, 2 or more, preferably 2.5 or more. The average functionality of the isocyanate groups (including free isocyanate groups and latent isocyanate groups) of the curing agent is, for example, 4 or less, preferably 3.5 or less.
[0212] More specifically, in this method, a base material capable of reacting with free isocyanate groups and an antibacterial agent as a curing agent are mixed to obtain a resin composition. The resin composition is then heated to deblock the latent isocyanate groups of the antibacterial agent without dissociating at least a portion of the tertiary ammonium salt, thereby obtaining free isocyanate groups. The free isocyanate groups are then reacted with the base material. This makes it possible to obtain a resin in which the antibacterial agent is fixed in the molecule. Examples of resins include polyurethane resins, polyester resins, and acrylic resins, and preferably polyurethane resins.
[0213] (2) Base The base agent is a component capable of reacting with the free isocyanate group obtained by deblocking the latent isocyanate group to form a resin. For example, when the resin is a polyurethane resin, the base agent may be, for example, an active hydrogen group-containing compound. The active hydrogen group-containing compound is a compound containing one or more active hydrogen groups in the molecule. Examples of the active hydrogen group-containing compound include polyol compounds and polyamine compounds. The active hydrogen group-containing compound is preferably, for example, a polyol compound.
[0214] The polyol compound includes, for example, a low molecular weight polyol and a high molecular weight polyol.
[0215] The number average molecular weight of the low-molecular-weight polyol is, for example, less than 300, and preferably less than 400. The low-molecular-weight polyol has two or more hydroxyl groups.
[0216] Low molecular weight polyols include, for example, dihydric alcohols, trihydric alcohols, tetrahydric alcohols, pentahydric alcohols, hexahydric alcohols, heptahydric alcohols, and octahydric alcohols. Examples of dihydric alcohols include ethylene glycol, propylene glycol, 1,3-propanediol, 1,4-butylene glycol, 1,3-butylene glycol, 1,2-butylene glycol, 1,5-pentanediol, 1,6-hexanediol, neopentyl glycol, 3-methyl-1,5-pentanediol, 2,2,2-trimethylpentanediol, 3,3-dimethylolheptane, alkane (C7-20) diols, 1,3-cyclohexanedimethanol, 1,4-cyclohexanedimethanol, 1,3-cyclohexanediol, 1,4-cyclohexanediol, hydrogenated bisphenol A, 1,4-dihydroxy-2-butene, 2,6-dimethyl-1-octene-3,8-diol, bisphenol A, diethylene glycol, triethylene glycol, and dipropylene glycol. Examples of trihydric alcohols include glycerin, trimethylolpropane, and triisopropanolamine. Examples of tetrahydric alcohols include tetramethylolmethane (pentaerythritol) and diglycerin. Examples of pentahydric alcohols include xylitol. Examples of hexahydric alcohols include sorbitol, mannitol, allitol, iditol, dulcitol, altritol, inositol, and dipentaerythritol. Examples of heptahydric alcohols include perseitol. Examples of octahydric alcohols include sucrose. The low molecular weight polyols can be used alone or in combination of two or more.
[0217] The number average molecular weight of the high molecular weight polyol is, for example, 300 or more, preferably 400 or more, and more preferably 500 or more. The high molecular weight polyol has two or more hydroxyl groups.
[0218] Examples of high molecular weight polyols include polyether polyols, polyester polyols, polycarbonate polyols, polyurethane polyols, epoxy polyols, vegetable oil polyols, polyolefin polyols, acrylic polyols, vinyl monomer modified polyols, and fluorine-containing polyols.
[0219] Examples of polyether polyols include polyoxyalkylene (C2-3) polyols and polytetramethylene ether polyols.
[0220] Examples of polyester polyols include adipic acid-based polyester polyols, phthalic acid-based polyester polyols, and lactone-based polyester polyols.
[0221] Examples of the polycarbonate polyol include a ring-opening polymer of ethylene carbonate using the above-mentioned low-molecular-weight polyol as an initiator, and an amorphous polycarbonate polyol obtained by copolymerizing the above-mentioned dihydric alcohol with the ring-opening polymer.
[0222] Examples of polyurethane polyols include polyester polyurethane polyols, polyether polyurethane polyols, polycarbonate polyurethane polyols, and polyester polyether polyurethane polyols.
[0223] The epoxy polyol may, for example, be an epoxy polyol obtained by reacting the above-mentioned low molecular weight polyol with a polyfunctional halohydrin.
[0224] Vegetable oil polyols include, for example, castor oil, coconut oil, and ester modified castor oil polyols.
[0225] Examples of polyolefin polyols include polybutadiene polyols and partial olefin polyols. transformation Examples include ethylene-vinyl acetate copolymers.
[0226] Examples of acrylic polyols include copolymers of hydroxyl group-containing acrylates and copolymerizable vinyl monomers copolymerizable with the hydroxyl group-containing acrylates.
[0227] The vinyl monomer modified polyol can be obtained by reacting the above-mentioned high molecular weight polyol with a vinyl monomer.
[0228] As the fluorine-containing polyol, for example, there can be mentioned an acrylic polyol in which a fluorine compound is blended as a copolymerizable vinyl monomer in the copolymerization of the acrylic polyol described above.
[0229] The high molecular weight polyols can be used alone or in combination of two or more kinds.
[0230] The polyol compounds can be used alone or in combination of two or more kinds.
[0231] Of the polyol compounds, preferably, high molecular weight polyols are used, and more preferably, polyurethane polyols and acrylic polyols are used.
[0232] The base material may contain additives. Examples of additives include reaction solvents, catalysts, epoxy resins, coating property improvers, leveling agents, defoamers, antioxidants, UV absorbers, thickeners, antisettling agents, plasticizers, surfactants, pigments, fillers, organic fine particles, inorganic fine particles, and antifungal agents. The amount of additives to be added is appropriately determined depending on the purpose and application.
[0233] (3) Resin composition In the production of the resin composition, the above-mentioned main agent and the antibacterial agent as a curing agent are mixed. The mixing ratio is appropriately set according to the purpose and use. For example, the equivalent ratio (latent isocyanate group / active hydrogen group) of the latent isocyanate group of the antibacterial agent to the active hydrogen group of the main agent (active hydrogen group-containing compound) is, for example, 0.1 or more, preferably 0.5 or more, more preferably 0.8 or more. In addition, the equivalent ratio (latent isocyanate group / active hydrogen group) of the latent isocyanate group of the antibacterial agent to the active hydrogen group of the main agent (active hydrogen group-containing compound) is, for example, 5 or less, preferably 3 or less, more preferably 1.2 or less.
[0234] The resin composition is then applied to an object by a known coating method and dried to form a coating film, which is then heated and aged as necessary.
[0235] The heating temperature and heating time are set so as to dissociate the blocking agent from the latent isocyanate groups.
[0236] The heating temperature is, for example, 50° C. or more, preferably 80° C. or more. The heating temperature is, for example, 180° C. or less, preferably 150° C. or less. The heating time is, for example, 10 seconds or more, preferably 30 seconds or more. The heating time is, for example, 10 minutes or less, preferably 5 minutes or less.
[0237] As a result, the latent isocyanate group of the antibacterial agent (non-antibacterial blocked capping group (C)) is deblocked, and a free isocyanate group is regenerated. The free isocyanate group of the antibacterial agent then reacts with the base resin to obtain a cured resin.
[0238] On the other hand, the quaternary ammonium group (antimicrobial-unblocked capping group (B)) remains in the antimicrobial agent. Also, when the antimicrobial agent contains a tertiary ammonium salt (antimicrobial-blocked capping group (D)), at least a portion of the tertiary ammonium salt remains in the antimicrobial agent.
[0239] Therefore, the above reaction fixes the quaternary ammonium group (and the tertiary ammonium salt) in the antibacterial agent to the resin, resulting in a resin (cured product) with excellent antibacterial properties.
[0240] Furthermore, when the antibacterial agent is blended in such a way that it is in excess, the excess antibacterial agent is contained in the resin (cured product) without reacting with the base resin, resulting in particularly excellent antibacterial properties being obtained by the excess antibacterial agent.
[0241] Examples of applications of such resin compositions (uncured products) and resins (cured products) include fiber treatment agents, water repellents, coating compositions, adhesives, antistatic agents, papermaking treatment agents, wet strength agents, receiving layers for recording media, electrodeposition coating compositions, antibacterial and antiviral compositions, encapsulated compositions, optical members, and latex compositions. Among the applications of the resin compositions (uncured products) and resins (cured products), preferred applications include fiber treatment agents, water repellents, coating compositions, and adhesives, and more preferred applications include fiber treatment agents and water repellents.
[0242] In the above description, the base agent reacts with the antibacterial agent as a curing agent to form a resin (cured product) having excellent antibacterial properties. However, the base agent and the antibacterial agent do not have to react. In this case, the antibacterial agent is encapsulated in the dried base agent and / or the cured base agent. Therefore, a resin (cured product) having excellent antibacterial properties is formed.
[0243] The antibacterial agent can also be cured by itself. For example, the antibacterial agent can be self-crosslinked and cured by coating or impregnating the substrate with the antibacterial agent and dissociating the blocking agent from the latent isocyanate group. For example, when the substrate has an active hydrogen group, the substrate and the antibacterial agent can be reacted to fix the antibacterial agent to the substrate. EXAMPLES
[0244] The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto. The specific numerical values of the blending ratio (content ratio), physical property values, parameters, etc. used in the following description can be replaced with the upper limit values (numerical values defined as "less than or equal to" or "less than") or lower limit values (numerical values defined as "more than or equal to" or "exceeding") of the corresponding blending ratio (content ratio), physical property values, parameters, etc. described in the above "Form for carrying out the invention". In addition, "parts" and "%" are based on mass unless otherwise specified.
[0245] Example 1 At room temperature (25°C), a 500 mL reactor equipped with a stirrer, a thermometer, a cooler, and a nitrogen gas inlet tube was charged with 50 parts by mass of an isocyanurate derivative of xylylene diisocyanate (XDI) (polyisocyanate compound, product name: Takenate D-131N, solid content 75 mass%, isocyanate group content 13.7%, manufactured by Mitsui Chemicals, Inc.) and acetonitrile (solvent).
[0246] Next, choline chloride was added to the reactor in an amount of moles shown in Tables 1 to 4 relative to 100 moles of isocyanate groups in the isocyanurate derivative of XDI.
[0247] The contents of the reactor were then heated to 75°C using a mantle heater to react the isocyanurate derivative of XDI with choline chloride. The isocyanate group concentration was measured to confirm that a portion of the isocyanate groups had been blocked by choline chloride.
[0248] Next, 3,5-dimethylpyrazole (DMP) was added to the reactor in an amount shown in Tables 1 to 4 per 100 moles of isocyanate groups in the isocyanurate derivative of XDI.
[0249] After that, by measuring the FT-IR spectrum of the reaction solution, it was confirmed that the remaining isocyanate groups were blocked by DMP to form blocked isocyanate groups. As a result, a reaction solution containing blocked isocyanate was obtained. The blocked isocyanate had a quaternary ammonium group derived from choline chloride and had excellent water dispersibility.
[0250] Then, 150 parts by mass of water was added to 50 parts by mass of the reaction liquid containing the blocked isocyanate. The reaction liquid and water were then emulsified by stirring with a homomixer. Next, the solvent was distilled off from the emulsion under reduced pressure conditions. and In both cases, a portion of the water was distilled off.
[0251] As a result, an aqueous dispersion of blocked isocyanate was obtained as an antibacterial agent. The solid content of the aqueous dispersion of blocked isocyanate was 20% by mass.
[0252] Examples 2 to 17 The formulation was changed as shown in Tables 1 to 4. Other than this, the same method as in Example 1 was used to obtain an aqueous dispersion of a blocked isocyanate as an antibacterial agent.
[0253] Example 18 At room temperature (25°C), a 500 mL reactor equipped with a stirrer, a thermometer, a cooler, and a nitrogen gas inlet tube was charged with 50 parts by mass of an isocyanurate derivative of xylylene diisocyanate (XDI) (polyisocyanate compound, product name: Takenate D-131N, solid content 75 mass%, isocyanate group content 13.7%, manufactured by Mitsui Chemicals, Inc.) and acetonitrile (solvent).
[0254] Next, choline chloride and methoxypolyoxyethylene glycol (MeOPEG, methoxy PEG1000, hydrophilic compound) were added to the reactor. The ratio of choline chloride added was the number of moles shown in Tables 1 to 4 relative to 100 moles of isocyanate groups in the isocyanurate derivative of XDI. The ratio of methoxypolyoxyethylene glycol added was the number of moles shown in Tables 1 to 4 relative to 100 moles of isocyanate groups in the isocyanurate derivative of XDI.
[0255] The content of the reactor was then heated to 75° C. with a mantle heater to react the isocyanurate derivative of XDI, choline chloride, and methoxypolyoxyethylene glycol. The isocyanate group concentration was measured to confirm that the isocyanurate derivative of XDI was modified with methoxypolyoxyethylene glycol (hydrophilic compound). The isocyanate group concentration was also measured to confirm that some of the isocyanate groups were substituted with choline chloride. To It was confirmed that the seal was better.
[0256] Next, 3,5-dimethylpyrazole (DMP) was added to the reactor in an amount shown in Tables 1 to 4 per 100 moles of isocyanate groups in the isocyanurate derivative of XDI.
[0257] Thereafter, the FT-IR spectrum of the reaction solution was measured to confirm that the remaining isocyanate groups were blocked by DMP to form blocked isocyanate groups. This resulted in a reaction solution containing blocked isocyanate. The blocked isocyanate had a quaternary ammonium group derived from choline chloride and an oxyethylene group derived from methoxypolyoxyethylene glycol (hydrophilic compound), and had excellent water dispersibility.
[0258] Then, 150 parts by mass of water was added to 50 parts by mass of the reaction liquid containing the blocked isocyanate. The reaction liquid and water were then emulsified by stirring with a homomixer. Next, the solvent was distilled off from the emulsion under reduced pressure conditions. and In both cases, a portion of the water was distilled off.
[0259] As a result, an aqueous dispersion of blocked isocyanate was obtained as an antibacterial agent. The solid content of the aqueous dispersion of blocked isocyanate was 20% by mass.
[0260] Example 19 At room temperature (25°C), a 500 mL reactor equipped with a stirrer, a thermometer, a cooler, and a nitrogen gas inlet tube was charged with 50 parts by mass of an isocyanurate derivative of xylylene diisocyanate (XDI) (polyisocyanate compound, product name: Takenate D-131N, solid content 75 mass%, isocyanate group content 13.7%, manufactured by Mitsui Chemicals, Inc.) and acetonitrile (solvent).
[0261] Next, choline chloride was added to the reactor in an amount of moles shown in Tables 1 to 4 relative to 100 moles of isocyanate groups in the isocyanurate derivative of XDI.
[0262] The contents of the reactor were then heated to 75°C using a mantle heater to react the isocyanurate derivative of XDI with choline chloride. The isocyanate group concentration was measured to confirm that a portion of the isocyanate groups had been blocked by choline chloride.
[0263] Next, 3,5-dimethylpyrazole (DMP) was added to the reactor in an amount shown in Tables 1 to 4 per 100 moles of isocyanate groups in the isocyanurate derivative of XDI.
[0264] Furthermore, 1,1,3,3-tetramethylguanidine (TMG) was added to the reactor in an amount shown in Tables 1 to 4 relative to 100 moles of isocyanate groups in the isocyanurate derivative of XDI.
[0265] After that, the FT-IR spectrum of the reaction solution was measured, and it was confirmed that the remaining isocyanate groups were partially blocked with DMP and partially sealed with TMG.
[0266] Next, acetic acid was added to the reaction solution and stirred. The ratio of acetic acid added was the number of moles shown in Tables 1 to 4 relative to 1 mole of TMG used. As a result, the tertiary amino group derived from TMG was neutralized by acetic acid to form a tertiary ammonium salt (ammonium acetate salt).
[0267] This resulted in a reaction liquid containing a blocked isocyanate. The blocked isocyanate had a quaternary ammonium group derived from choline chloride and a tertiary ammonium salt (ammonium acetate salt) derived from TMG and acetic acid, and had excellent water dispersibility.
[0268] Then, 150 parts by mass of water was added to 50 parts by mass of the reaction liquid containing the blocked isocyanate. The reaction liquid and water were then emulsified by stirring with a homomixer. Next, the solvent was distilled off from the emulsion under reduced pressure conditions. and In both cases, a portion of the water was distilled off.
[0269] As a result, an aqueous dispersion of blocked isocyanate was obtained as an antibacterial agent. The solid content of the aqueous dispersion of blocked isocyanate was 20% by mass.
[0270] Example 20 At room temperature (25°C), a 500 mL reactor equipped with a stirrer, a thermometer, a cooler, and a nitrogen gas inlet tube was charged with 50 parts by mass of an isocyanurate derivative of xylylene diisocyanate (XDI) (polyisocyanate compound, product name: Takenate D-131N, solid content 75 mass%, isocyanate group content 13.7%, manufactured by Mitsui Chemicals, Inc.) and acetonitrile (solvent).
[0271] Next, choline chloride and methoxypolyoxyethylene glycol (methoxypolyethylene glycol, methoxy PEG1000, hydrophilic compound) were added to the reactor. The ratio of choline chloride added was the number of moles shown in Tables 1 to 4 relative to 100 moles of isocyanate groups in the isocyanurate derivative of XDI. The ratio of methoxypolyoxyethylene glycol added was the number of moles shown in Tables 1 to 4 relative to 100 moles of isocyanate groups in the isocyanurate derivative of XDI.
[0272] The content of the reactor was then heated to 75° C. with a mantle heater to react the isocyanurate derivative of XDI, choline chloride, and methoxypolyoxyethylene glycol. The isocyanate group concentration was measured to confirm that the isocyanurate derivative of XDI was modified with methoxypolyoxyethylene glycol (hydrophilic compound). The isocyanate group concentration was also measured to confirm that some of the isocyanate groups were substituted with choline chloride. To It was confirmed that the seal was better.
[0273] Next, 3,5-dimethylpyrazole (DMP) was added to the reactor in an amount shown in Tables 1 to 4 per 100 moles of isocyanate groups in the isocyanurate derivative of XDI.
[0274] Furthermore, 1,1,3,3-tetramethylguanidine (TMG) was added to the reactor in an amount shown in Tables 1 to 4 relative to 100 moles of isocyanate groups in the isocyanurate derivative of XDI.
[0275] After that, the FT-IR spectrum of the reaction solution was measured, and it was confirmed that the remaining isocyanate groups were partially blocked with DMP and partially sealed with TMG.
[0276] Next, acetic acid was added to the reaction solution and stirred. The ratio of acetic acid added was the number of moles shown in Tables 1 to 4 relative to 1 mole of TMG used. As a result, the tertiary amino group derived from TMG was neutralized by acetic acid to form a tertiary ammonium salt (ammonium acetate salt).
[0277] This resulted in a reaction liquid containing a blocked isocyanate. The blocked isocyanate had a quaternary ammonium group derived from choline chloride, an oxyethylene group derived from methoxypolyoxyethylene glycol (a hydrophilic compound), and a tertiary ammonium salt (ammonium acetate salt) derived from TMG and acetic acid, and had excellent water dispersibility.
[0278] Then, 150 parts by mass of water was added to 50 parts by mass of the reaction liquid containing the blocked isocyanate. The reaction liquid and water were then emulsified by stirring with a homomixer. Next, the solvent was distilled off from the emulsion under reduced pressure conditions. and In both cases, a portion of the water was distilled off.
[0279] As a result, an aqueous dispersion of blocked isocyanate was obtained as an antibacterial agent. The solid content of the aqueous dispersion of blocked isocyanate was 20% by mass.
[0280] Example 21 At room temperature (25°C), a 500 mL reactor equipped with a stirrer, a thermometer, a cooler, and a nitrogen gas inlet tube was charged with 50 parts by mass of an isocyanurate derivative of xylylene diisocyanate (XDI) (polyisocyanate compound, product name: Takenate D-131N, solid content 75 mass%, isocyanate group content 13.7%, manufactured by Mitsui Chemicals, Inc.) and acetonitrile (solvent).
[0281] Next, dimethylaminoethanol (DMAE) was added to the reactor in an amount of moles shown in Tables 1 to 4 relative to 100 moles of isocyanate groups in the isocyanurate derivative of XDI.
[0282] The contents of the reactor were then heated to 75°C using a mantle heater to react the isocyanurate derivative of XDI with DMAE. The isocyanate group concentration was measured to confirm that a portion of the isocyanate groups had been blocked with DMAE.
[0283] Next, 3,5-dimethylpyrazole (DMP) was added to the reactor in an amount shown in Tables 1 to 4 per 100 moles of isocyanate groups in the isocyanurate derivative of XDI.
[0284] Next, the FT-IR spectrum of the reaction solution was measured, and it was confirmed that the remaining isocyanate groups had been blocked with DMP to form blocked isocyanate groups.
[0285] Thereafter, methyl chloride (about 5.7% tetrahydrofuran solution, manufactured by Tokyo Chemical Industry Co., Ltd.) was added to the reaction solution, whereby the tertiary amino groups derived from DMAE were converted to quaternary amino groups.
[0286] This resulted in a reaction liquid containing a blocked isocyanate. The blocked isocyanate had quaternary ammonium groups derived from DMAE and methyl chloride and had excellent water dispersibility.
[0287] Then, 150 parts by mass of water was added to 50 parts by mass of the reaction liquid containing the blocked isocyanate. The reaction liquid and water were then emulsified by stirring with a homomixer. Next, the solvent was distilled off from the emulsion under reduced pressure conditions. and In both cases, a portion of the water was distilled off.
[0288] Comparative Example 1 Instead of the isocyanurate derivative of xylylene diisocyanate (XDI), an isocyanurate derivative of hexamethine diisocyanate (HDI) (polyisocyanate compound, product name: Takenate D-170N, solid content 100 mass%, isocyanate group content 20.7%, manufactured by Mitsui Chemicals, Inc.) was used. Also, choline chloride was not used. Other than these, an aqueous dispersion of blocked isocyanate was obtained as an antibacterial agent in the same manner as in Example 19. The solids concentration of the aqueous dispersion of the blocked isocyanate was 20% by mass.
[0289] Comparative Example 2 Instead of the isocyanurate derivative of xylylene diisocyanate (XDI), an isocyanurate derivative of hexamethine diisocyanate (HDI) (polyisocyanate compound, product name: Takenate D-170N, solid content 100 mass%, isocyanate group content 20.7%, manufactured by Mitsui Chemicals, Inc.) was used. Also, choline chloride was not used. Other than these, an aqueous dispersion of blocked isocyanate was obtained as an antibacterial agent in the same manner as in Example 18. The solids concentration of the aqueous dispersion of the blocked isocyanate was 20% by mass.
[0290] Synthesis Example 1 (Preparation of Base Agent for Evaluation) At room temperature (25°C), 703.3 parts by mass of polytetramethylene ether glycol (product name: PTG-2000SN, manufactured by Hodogaya Chemical Co., Ltd.), 52.8 parts by mass of triethylene glycol (manufactured by Tokyo Chemical Industry Co., Ltd.), 144.6 parts by mass of N-methyldiethanolamine (manufactured by Tokyo Chemical Industry Co., Ltd.), and 293.3 parts by mass of acetonitrile were charged into a 3 L reactor equipped with a stirrer, a thermometer, a cooler, and a nitrogen gas inlet tube, and the mixture was stirred for 30 minutes at a liquid temperature of 40°C or less.
[0291] Next, 346.1 parts by mass of 1,3-bis(isocyanatomethyl)cyclohexane (product name: Takenate 600, manufactured by Mitsui Chemicals, Inc.) was added to the reactor, and the 1,3-bis(isocyanatomethyl)cyclohexane, polytetramethylene ether glycol, triethylene glycol, and N-methyldiethanolamine were reacted for 30 minutes.
[0292] Thereafter, 0.4 parts by mass of stannous octylate (product name: Stanoct, manufactured by Mitsubishi Chemical Corporation) was added to the reactor, and the reactor was heated until the liquid temperature reached 75°C. Then, 1,3-bis(isocyanatomethyl)cyclohexane, polytetramethylene ether glycol, triethylene glycol, and N-methyldiethanolamine were reacted at a liquid temperature of 75°C for 3 hours. Thereafter, the FT-IR spectrum was measured to confirm that the isocyanate groups had reacted. As a result, a polyurethane resin was produced.
[0293] Thereafter, the reaction liquid containing the polyurethane resin was cooled to room temperature (25° C.), and 72.9 parts by mass of acetic acid and 586.7 parts by mass of acetonitrile were added to the reaction liquid, followed by stirring for 1 hour. As a result, an acetonitrile solution of a polyurethane resin was obtained.
[0294] Next, 4431.8 parts by mass of water cooled to 15°C to 25°C was charged into a 20L SUS container, and 2083.3 parts by mass of the acetonitrile solution of polyurethane resin was added to the water while stirring with a homomixer. of Add and emulsify.
[0295] Next, acetonitrile (solvent) is distilled off from the emulsion under reduced pressure. and In both cases, a portion of the water was distilled off.
[0296] In this manner, an aqueous dispersion of polyurethane resin was prepared. The aqueous dispersion of polyurethane resin had a solids concentration of 26.2% by mass.
[0297] <Evaluation> <1;Water dispersibility> As described in each Example and Comparative Example, water was added to the reaction liquid containing the blocked isocyanate, and the reaction liquid and water were emulsified by stirring with a homomixer. The dispersibility of the reaction liquid in water at this time was evaluated as the water dispersibility of the blocked isocyanate. The evaluation criteria are as follows.
[0298] ◯: The reaction liquid containing the blocked isocyanate disperses quickly in water. △: The reaction liquid containing the blocked isocyanate disperses in water after stirring for a long period of time (0.5 hours or more). ×: The reaction solution containing the blocked isocyanate does not disperse in water. Precipitation occurs.
[0299] <2; Storage stability> The aqueous dispersion of the blocked isocyanate was placed in a container. The aqueous dispersion of the blocked isocyanate was allowed to stand at 25°C for 7 days. Thereafter, the storage stability of the aqueous dispersion was visually evaluated on a 5-point scale according to the following criteria. In each of the following evaluations, 5 is the best and 1 is the worst.
[0300] 5: No precipitation was observed in the aqueous dispersion, and no deposits were observed on the container walls. 4: No precipitation was observed in the aqueous dispersion, and a small amount of adhesion was observed on the wall of the container. 3: No precipitation was observed in the aqueous dispersion, and adhesion was observed on the container wall. 2: A small amount of precipitation was observed in the aqueous dispersion, and adhesion was observed on the container wall. 1: Precipitation was observed in the aqueous dispersion, and adhesion was observed on the container wall.
[0301] <3; Antibacterial properties (film test)> (Test bacterial species) Escherichia Coli (E. coli, NBRC-3972, provided by National Institute of Technology and Evaluation, E. coli)
[0302] Based on JIS Z 2801:2010 "Antibacterial products - Antibacterial test methods, antibacterial effect", E. coli The antibacterial activity against was evaluated.
[0303] (1) A mixture was obtained by mixing 1.8 parts by mass (solid content basis) of the blocked isocyanate of each Example and Comparative Example, 88.2 parts by mass (solid content basis) of Takelac W-6355 (product name, water-based polyurethane resin, manufactured by Mitsui Chemicals, Inc.), and 10.0 parts by mass of isopropyl alcohol. Further, water was added to the mixture to adjust the solid content concentration of the mixture to 10% by mass.
[0304] Next, the above mixture was applied onto a polyethylene terephthalate film (trade name: Lumirror S10, manufactured by Toray Industries, Inc.) using a bar coater, and cured by heating at 150° C. for 2 minutes, thereby obtaining a film having a thickness of 0.1 to 2.0 μm.
[0305] (2) The film was cut into a square of 50±2 mm on each side to prepare a test specimen. The test specimen was placed in a sterilized plastic petri dish and the test bacteria liquid (bacterial count 2.5×10 5 pieces / mL~10×10 5 The test bacteria solution was prepared as follows:
[0306] That is, the cultured bacteria was precultured in an incubator at a temperature of 35±1° C. for 20±4 hours in LB medium (BD Difco (trade name) LB Broth Miller, Becton Dickinson and Company) (first liquid).
[0307] Next, the first liquid was further inoculated onto a slant medium (nutrient agar, Merck) and pre-cultured in an incubator at a temperature of 35±1° C. for 20±4 hours (second liquid).
[0308] Thereafter, the second solution was appropriately adjusted in concentration with separately prepared 1 / 500 nutrient broth (Merck) (third solution).
[0309] (3) On the other hand, a polyethylene terephthalate film (trade name: Lumirror S10, manufactured by Toray Industries, Inc.) measuring 50±2 mm square was prepared as a control sample, and the test bacterial liquid was inoculated into the film in the same manner as the test specimen.
[0310] (4) Next, a 40±2 mm square biaxially oriented polypropylene (OPP) film was placed over the inoculated test solution, allowing the test solution to be evenly inoculated over the entire film.Then, the film was cultured at a temperature of 35±1°C and a relative humidity of 85±5% for 20±4 hours.
[0311] (5) Immediately after inoculation of the test bacteria solution or after the cultivation in (4) above, 10 mL of SCDLP medium (SCDLP medium Daigo (trade name), manufactured by Nippon Pharmaceutical Co., Ltd.) was added, and the test bacteria solution on the test piece was washed four or more times to completely recover the bacteria solution. The recovered liquid (washed out liquid) was promptly subjected to the next process, and the viable bacteria count was measured.
[0312] (6) The liquid recovered in (5) above (washout liquid) and phosphate buffered saline were used to prepare a 10-fold serial dilution.
[0313] Then, each dilution series was mixed with a standard agar medium (Standard Agar Medium Daigo (trade name), product of Nippon Pharmaceutical Co., Ltd.) to prepare a medium. The medium was then cultured at a temperature of 35±1°C for 20±4 hours, after which the number of colonies was measured. The petri dishes of the dilution series on which 30 to 300 colonies appeared were counted.
[0314] (7) Based on the measurement results, the viable cell count was calculated using the following formula. N=C×D×V / A N: Number of live bacteria (1 cm test piece) 2 Around C: Number of villages D: Dilution ratio (the dilution ratio of each diluted solution in the petri dish used) V: Volume of SCDLP medium used for washing (mL) A: Surface area of the coating film (cm 2 )
[0315] (8) The antibacterial activity value was calculated using the following formula. R = (Ut-U0) - (At-U0) = Ut-At R: Antibacterial activity value U0: The average logarithmic value of the number of viable bacteria immediately after inoculation of the untreated test piece Ut: The average logarithm of the number of viable bacteria on the untreated test piece after 24 hours At: The average logarithmic value of the number of viable bacteria on the antibacterial treated test piece after 24 hours
[0316] The results were then rated on a three-point scale based on the following criteria, with 3 being the best and 1 being the worst.
[0317] 3: Antibacterial activity value R is 3.0 or more (strong antibacterial activity) 2: Antibacterial activity value R is 2.0 or more and less than 3.0 (antibacterial activity present) 1: Antibacterial activity value R is less than 2.0 (no antibacterial activity)
[0318] <4; Antibacterial properties (fiber test)> (Test bacterial species) Staphylococcus aureus (S. aureus, NBRC-12732, provided by National Institute of Technology and Evaluation, Staphylococcus aureus)
[0319] The antibacterial activity against Staphylococcus aureus was evaluated as follows, based on the "bacterial liquid absorption method" described in JIS L 1902:2015 "Antibacterial test methods and antibacterial effects of textile products."
[0320] (1) A mixture was obtained by mixing 1.8 parts by mass (solid content basis) of the blocked isocyanate of each Example and Comparative Example, 88.2 parts by mass (solid content basis) of the polyurethane resin of Synthesis Example 1, and 10.0 parts by mass of isopropyl alcohol. Water was then added to the mixture to adjust the solid content concentration of the mixture to 10% by mass.
[0321] Next, a cotton cloth (25 cm long x 25 cm wide, JIS L0803 compliant, Kanakin No. 3) was immersed in the above mixture. The cotton cloth was then pulled out of the mixture and thoroughly wrung out. The cotton cloth was then dried in a dark place at room temperature (25°C) for 24 hours. The dried cotton cloth was then dried in a heating oven at 150°C for 2 minutes. This resulted in an antibacterial test piece.
[0322] (2) 0.4 g of antibacterial test specimens were placed in a glass bottle, and 0.2 mL of test bacteria liquid was dropped onto the antibacterial test specimens. The glass bottles were then capped and cultured at 37°C for 24 hours. Next, 20 mL of washout liquid was added to the glass bottle to wash out the bacteria liquid from the antibacterial test specimens. The number of live bacteria in the washout liquid was then measured using the pour plate culture method or luminescence measurement method.
[0323] (3) Based on the measurement results, the antibacterial activity value was calculated using the following formula. R = (Ct-C0)-(Tt-T0) R: Antibacterial activity value C0: The average logarithmic value of the number of viable bacteria immediately after inoculation of the untreated test piece Ct: The average logarithm of the number of viable bacteria on untreated test pieces after 24 hours T0: The average logarithmic value of the number of viable bacteria immediately after inoculation of the antibacterial test piece Tt: The average logarithmic value of the number of live bacteria on the antibacterial treated test piece after 24 hours
[0324] The results were then rated on a three-point scale based on the following criteria, with 3 being the best and 1 being the worst.
[0325] 3: Antibacterial activity value R is 3.0 or more (strong antibacterial activity) 2: Antibacterial activity value R is 2.0 or more and less than 3.0 (antibacterial activity present) 1: Antibacterial activity value R is less than 2.0 (no antibacterial activity)
[0326] <5;Curing property (reactivity)> The aqueous dispersion (polyisocyanate component) of the blocked isocyanate of each Example and Comparative Example was mixed with the aqueous dispersion (polyol component) of the polyurethane resin of Synthesis Example 1 synthesized in Synthesis Example 1. The ratio of the solid content mass of the aqueous dispersion of the blocked isocyanate to the solid content mass of the aqueous dispersion of the polyurethane resin of Synthesis Example 1 was 1 / 6.
[0327] Thereafter, water was added to the mixed dispersion of the aqueous dispersion of the blocked isocyanate and the aqueous dispersion of the polyurethane resin of Synthesis Example 1 to adjust the final solid content concentration to 20 mass %.
[0328] Furthermore, a leveling agent (product name: BYK-348, manufactured by BYK Japan) was added to the mixed dispersion and stirred for 30 minutes. The addition ratio of the leveling agent was 0.5 parts by mass with respect to 100 parts by mass of the mixed dispersion.
[0329] In this way, a liquid for evaluating curability was prepared.
[0330] Next, the curing evaluation liquid was applied to a polypropylene substrate. Then, the coating of the curing evaluation liquid was applied to a polypropylene substrate by 120 ℃ The mass of the cured coating film was measured, and then the film was immersed in a mixed solvent of acetone and methanol in a mass ratio of 1:1 for 24 hours.
[0331] The gel content was then removed by filtration, and the coating was dried at 110°C for 3 hours, and the mass of the coating film after immersion was measured. The gel fraction was calculated using the following formula. The mass of the cured coating film before immersion in the mixed solvent was taken as mass A, and the mass of the coating film after immersion in the mixed solvent was taken as mass B.
[0332] Gel fraction (%) = 100 × mass B / mass A
[0333] The curability of the blocked isocyanate when the coating film curing temperature was 120° C. was evaluated on a five-point scale according to the following criteria.
[0334] 4: Gel fraction is 60% or more. 3: Gel fraction is 50% or more and less than 60%. 2: Gel fraction is 40% or more and less than 50%. 1: Gel fraction is 0% or more and less than 40%.
[0335] <6;Lightfastness> The aqueous dispersion (polyisocyanate component) of the blocked isocyanate of each Example and Comparative Example was mixed with the aqueous dispersion (polyol component) of the polyurethane resin of Synthesis Example 1. The ratio of the solid content mass of the aqueous dispersion of the blocked isocyanate to the solid content mass of the aqueous dispersion of the polyurethane resin was 1 / 6.
[0336] Thereafter, water was added to the mixed dispersion of the aqueous dispersion of the blocked isocyanate and the aqueous dispersion of the polyurethane resin of Synthesis Example 1 to adjust the final solid content concentration to 20 mass %.
[0337] Furthermore, a leveling agent (product name: BYK-348, manufactured by BYK Japan) was added to the mixed dispersion and stirred for 30 minutes. The addition ratio of the leveling agent was 0.5 parts by mass with respect to 100 parts by mass of the mixed dispersion. In this way, a curing evaluation liquid was prepared.
[0338] Next, the curing evaluation liquid was applied to a polypropylene substrate. ℃ The mixture was cured at RT for 30 min.
[0339] After that, a weather meter FDP manufactured by Suga Testing Instruments was used to measure the temperature under daytime conditions (28W / m 2 , 60℃, 10% relative humidity, 4 hours) and night conditions (0W / m 2 The coating film was subjected to a light resistance test by alternately subjecting the coating to a temperature of 50°C, 100% relative humidity, and 4 hours.
[0340] Then, using a MINOLTA color difference meter CR-200, the yellowing degree (b * The yellowing degree before the light fastness test was measured. * The change in yellowing degree when (0) is taken as * ) was calculated using the following formula: Δb * =b * -b * (0)
[0341] The change in yellowing was evaluated according to the following criteria, with light resistance being judged to be higher in the order of 1 to 3.
[0342] 3 points (○); Change in yellowing degree (Δb * ) is less than 1 2 points (△); Change in yellowing degree (Δb * ) is 1 or more and less than 3 1 point (×); Change in yellowing degree (Δb * ) is 3 or more
[0343] [Table 1]
[0344] [Table 2]
[0345] [Table 3]
[0346] [Table 4]
[0347] Details of the abbreviations in the table are given below. D-131N: isocyanurate derivative of xylylene diisocyanate (XDI), product name: Takenate D-131N, solid content 75% by mass, isocyanate group content 13.7%, manufactured by Mitsui Chemicals, Inc. D-170N: Isocyanurate derivative of hexamethine diisocyanate (HDI), product name: Takenate D-170N, solid content 100% by mass, isocyanate group content 20.7%, manufactured by Mitsui Chemicals, Inc. D-127N: Isocyanurate of 1,3-bis(isocyanatomethyl)cyclohexane (1,3-H6XDI), product name: Takenate D-127N, solid content 75% by mass, isocyanate group content 13.5%, manufactured by Mitsui Chemicals, Inc. D-370N: Isocyanurate of pentamethylene diisocyanate (PDI), product name: STABIO D-370N, solid content 100% by mass, isocyanate group content 25%, manufactured by Mitsui Chemicals D-204: Isocyanurate of tolylene diisocyanate (TDI), product name: Takenate D-204, solid content 50% by mass, isocyanate group content 7.5%, manufactured by Mitsui Chemicals D-110N: Trimethylolpropane (TMP) adduct of xylylene diisocyanate (XDI), product name: Takenate D-110N, solid content 75% by mass, isocyanate group content 11.5%, manufactured by Mitsui Chemicals TMG; 1,1,3,3-tetramethylguanidine DMAE; Dimethylaminoethanol DMP; 3,5-dimethylpyrazole MEKO; Methyl ethyl ketone oxime IMZ; Imidazole DiPA; Diisopropylamine MeOPEG; methoxypolyoxyethylene glycol, methoxyPEG1000, hydrophilic compound
[0348] Example 22 The antibacterial agent of Example 1 was diluted with water to obtain an antibacterial dilution. The solid content concentration of the antibacterial dilution was 0.84% by mass. Next, a standard cloth for antibacterial testing (cotton) (manufactured by the Japan Textile Evaluation Technology Council) was immersed in the above-mentioned antibacterial dilution. Next, the standard cloth for antibacterial testing was pulled out of the antibacterial dilution. The standard cloth for antibacterial testing was also squeezed so that the wet pickup was 100%. The standard cloth for antibacterial testing was also left in a dark place and dried at room temperature (25°C) for 24 hours. After that, the dried standard cloth for antibacterial testing was dried in a heating oven at 170°C for 3 minutes. This resulted in an antibacterial-treated test cloth.
[0349] Next, in accordance with JIS L 1930:2014 "Home washing test method for textile products," the antibacterial test fabric was washed 10 times using JAFET standard detergent blend.
[0350] Thereafter, the antibacterial properties of the antibacterial test cloth that had been washed 10 times and the antibacterial properties of the antibacterial test cloth that had not been washed were evaluated. More specifically, the antibacterial properties against Staphylococcus aureus were evaluated by the method described above in "4; Antibacterial properties (textile test)" with reference to the "bacterial liquid absorption method" described in JIS L 1902:2015 "Antibacterial properties test method and antibacterial effect of textile products."
[0351] As a result, the antibacterial activity value R of the unwashed antibacterial test cloth was 2.0 or more. This result confirmed that the above antibacterial agent exhibited antibacterial properties by itself.
[0352] In addition, the antibacterial activity value R of the antibacterial test cloth after 10 washes was also 2.0 or more. This result confirmed that the antibacterial properties were maintained even after washing.
[0353] The above invention is provided as an exemplary embodiment of the present invention, but this is merely an example and should not be interpreted as being limited. Modifications of the present invention that are obvious to those skilled in the art are included in the scope of the following claims. [Industrial Applicability]
[0354] The antibacterial agent of the present invention is suitably used in the fields of fiber treatment agents, water repellents, coating compositions, adhesives, antistatic agents, papermaking treatment agents, wet strength agents, receiving layers for recording media, electrodeposition coating compositions, antibacterial and antiviral compositions, encapsulated compositions, optical members, and latex compositions.
Claims
1. It is an antibacterial agent containing a blocked isocyanate. The blocked isocyanate is A blocking residue of a polyisocyanate (A); an antibacterial-nonblocking capping group (B); and a non-antibacterial blocking group (C); The blocked residue (A) of the polyisocyanate is obtained by blocking the isocyanate groups of a polyisocyanate having a plurality of isocyanate groups, The antibacterial non-blocked capping group (B) is formed by irreproducibly blocking at least a portion of the isocyanate groups, The non-antibacterial blocked capping group (C) is formed by reproducibly blocking at least a portion of the isocyanate groups, the antimicrobial-nonblocking capping group (B) comprises a quaternary ammonium group; The quaternary ammonium group includes a trialkylammonium group formed by a counterion, The antibacterial agent, wherein the antibacterial non-blocked capping group (B) is formed by reaction of at least a portion of the plurality of isocyanate groups with at least one active hydrogen group selected from the group consisting of a hydroxyl group, an amino group, and a mercapto group.
2. the blocked isocyanate further comprises an antimicrobial-blocked capping group (D); The antibacterial blocked capping group (D) is formed by reproducibly blocking at least a portion of the isocyanate groups, The antimicrobial agent of claim 1 , wherein the antimicrobial-blocking capping group (D) comprises a tertiary ammonium salt.
3. The blocked isocyanate further comprises a hydrophilic group (E), The hydrophilic group (E) is formed by blocking at least a part of the isocyanate groups so that they cannot be regenerated, The antimicrobial agent of claim 1 , wherein the hydrophilic group (E) comprises a polyoxyethylene group.
4. The antimicrobial agent according to claim 1 , wherein the blocked isocyanate is not quaternized.
5. The blocked isocyanate is a reaction product of raw material components, The raw material ingredients are A polyisocyanate (a) having a plurality of isocyanate groups and for forming the capping residue (A); an antimicrobial-unblocked capping agent (b) for reacting with at least a portion of said plurality of isocyanate groups to form said antimicrobial-unblocked capping groups (B); a non-antimicrobial-blocked capping agent (c) for reacting with at least a portion of said plurality of isocyanate groups to form said non-antimicrobial-blocked capping groups (C); The antimicrobial agent of claim 1, wherein the antimicrobial-non-blocking sealant (b) comprises a quaternary ammonium group-containing compound.
6. The antibacterial agent according to claim 5, wherein the proportion of the antibacterial non-blocking sealant (b) is 5 moles or more per 100 moles of isocyanate groups of the polyisocyanate (a).
7. The antimicrobial agent of claim 5 , wherein the quaternary ammonium group-containing compound comprises a trialkylalkanol ammonium compound.
8. The raw material components further include a tertiary amino group-containing compound (d1) for reacting with at least a portion of the multiple isocyanate groups to add a tertiary amino group; an acid (d2) for neutralizing at least a portion of the tertiary amino groups to form a tertiary ammonium salt; The antimicrobial agent of claim 5 .
9. The raw material component further contains a hydrophilic compound (e), The antimicrobial agent of claim 5 , wherein the hydrophilic compound (e) comprises a polyoxyethylene compound.
10. The antimicrobial agent of claim 1 , wherein the polyisocyanate comprises an araliphatic polyisocyanate derivative.
Citation Information
Patent Citations
Crosslinking agent for fiber or leather, treatment agent and structure
JP2019112510A
Article comprising immobilized antibacterial agent and method for producing same
WO2013047642A1
Blocked isocyanate composition, prepolymer composition, method for producing these, and thermally dissociative blocking agent of blocked isocyanate composition
WO2017038863A1
